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ABSTRACT
Development of a Cell-Depositing System Using Inkjet Technology
Jason Robert Ozaeta

In the past decade, advances in tissue engineering have allowed researchers to
fabricate simple tissues. However, the process of creating these native tissues is a time
consuming and inefficient process. A scaffold must first be fabricated then exposed to a
sea of cells in the hopes of seeding. Furthermore, even though cells may have attached,
more time must be spent in order to allow the cells to migrate to their ideal locations. To
deal with this problem, researchers have investigated whether rapid prototyping
principals could be adapted to facilitate the cell seeding process by placing cells in their
respective locations during scaffold fabrication. The goal for this thesis was to establish
the foundation for a cell-compatible printer that, in the future, could fabricate pre-seeded
scaffolds. This task included implementing changes to a commercial solenoid-based
inkjet system that would allow cells to be loaded into the printer in a sterile fashion. In
addition, protocols had to be designed with system limitations in mind. An initial test
with the designed system showed a majority of cell viability percentages above 90%. If
additional tests confirm this possibility, the system should be further modified to provide
cells with a proper culturing environment. Furthermore, additional research would need
to be performed in order to determine whether scaffolding materials can be dispensed
through the system to fabricate scaffolds.
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1.0

INTRODUCTION
There is a growing concern in the medical field regarding tissue damage

treatments, where a declining trend can be seen in tissue availability. For example, the
number of U.S. patients on the kidney transplant active waiting list is increasing. In
1996, the waiting list had about 29,000 patients; in 2006, there were over 45,000. In
contrast, the number of patients that actually received a transplant increased from about
10,000 to only about 16,000 patients [61]. This widening gap in transplant supply-anddemand demonstrates that organ transplant surgery is unable to meet the growing demand
for tissue. Furthermore, the few patients that are able to receive the vital organ transplant
will most likely require immunosuppressant therapy for the rest of their lives to prevent
tissue rejection. Other options for tissue-replacement patients do not offer much
potential, either. Surgical reconstruction, for example, is affected by similar donor
shortage problems, as well as the risk of donor site morbidity. The third option, artificial
organs and/or mechanical intervention, puts patients at risk for thrombosis and infection.
Furthermore, mechanical devices currently have a limited lifespan [16]. With these
limitations in mind, researchers looked for a new way to tackle the rising tissue shortage.
In 1987, researchers established a new field of study to specifically tackle this
tissue shortage. Tissue engineering is defined as an interdisciplinary field that applies the
principles of engineering and life sciences towards the development of biological
substitutes that restore, maintain, or improve tissue function [69]. This field combines
the efforts of cell biologists, engineers, material scientists, mathematicians, geneticists,
and clinicians to fabricate new tissue that can mimic native tissue function [16].
Furthermore, to serve as a better alternative than the previously mentioned clinical
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treatments, these engineered tissues also need to elicit no major immunogenic responses.
Tissue engineering potentially can offer doctors the ability to repair damaged tissue much
more effectively than current clinical methods.
The current technique for engineering tissue, described in greater detail later in
this paper, involves the use of pre-made scaffolds, which are 2D or 3D structures onto
which cells can adhere to and develop on. These scaffolds, which also facilitate nutrient
transport and provide mechanical support for the cells, require a complex network of
interconnecting pores for adequate nutrient diffusion throughout the structure [31]. This
complex pore network, however, cannot easily be fabricated using traditional
manufacturing techniques. Furthermore, depending on the size of the scaffold, the cells
cannot always diffuse through the entire scaffold to fully seed the construct. These issues
stress a need for a better method of tissue fabrication.
Researchers began to investigate another recently developed technology to
possibly resolve these issues. Rapid prototyping (RP) evolved out of a need to visualize
and test a product without sacrificing time. The key to rapid prototyping is cheap, easily
fused/bound material(s) and a layer-based assembly method. For tissue engineers,
however, the ability to build complex shapes layer-by-layer could allow for the creation
of better scaffolds. By creating an interconnected porous substructure, researchers
believe that these scaffolds will allow for better tissue properties.
However, while RP systems have been increasingly used for scaffold research,
relatively few studies have been examined the possibility of RP-based cell seeding.
Although RP devices can build a scaffold on-demand, most researchers still seed cells the
“classical” way, following scaffold production. If a scaffold can be built layer-by-layer
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to generate complex patterns, why can’t the same system also strategically place cells for
better migration and tissue function? Since tissues rely on groups of cells that are not
randomly distributed within its matrix, tissue-engineering techniques should be designed
to best place the cells without relying too heavily on uniform cell distribution to achieve
this goal.
This thesis project was intended to create a proof-of-concept for a potential RP
system that is capable of seeding cells onto specific locations. An existing commercial
ink-jet system was modified to accept a variety of fluids. A closed-system fluid reservoir
was developed to maximize sterility at the inlet, and a protocol was developed to
maximize the system’s sterility prior to depositing cells. If everything works as planned,
this system should be able to dispense viable cells. The long-term goal for this project is
to develop a novel, low-cost RP system capable of constructing a 3D bioactive scaffold
autonomously. The multiple ink-jet heads should make it possible to dispense different
materials simultaneously. As a result, it should be possible, in the future, to integrate
cells into a scaffold as the construct is being built. While far from complete realization,
achieving such a goal could lead to the solution for our growing tissue shortage.
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2.0

TISSUE ENGINEERING FUNDAMENTALS
The field of tissue engineering requires a vast body of information. This large

knowledge base comes from the wide variety of disciplines involved in this research
field. Therefore, to understand this interdisciplinary field, one needs to understand the
basics of some of these disciplines. On the biological side, one should be familiar with
the individual components in the body that allow for tissue formation: the extracellular
matrix, cells, and other stimuli. Because this field is still relatively young, new and
different techniques are always being developed, and sometimes can be hard to follow.
Therefore, one should also understand the basic fundamentals of the classical tissue
engineering approach in order to understand the need for researching new techniques.

2.1

What Are Tissues?
Tissues can be defined as a collection of similar cells that perform a common

function. In order to understand this definition, one should consider differences between
unicellular and multi-cellular organisms. A unicellular organism is the most basic of
organisms, dedicated to performing a single function. Multi-cellular organisms, as
implied by its name, contain many cells. If one assumes that different cells perform
different functions, then a multi-cellular organism could potentially perform more
complex functions. In a competitive environment, these organisms need to maximize its
survivability. As a result, organization of the cells is required, as grouping similar cells
or cells that work best together can optimize throughput. These groupings ultimately lead
to a separation of specialized cells, better known as a tissue.
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Tissues can be classified into four major categories: muscle, connective, nervous,
and epithelial. The primary function of all muscle tissue is to provide contractile force.
In comparison to muscles, connective tissue provides little or no contractile force. As its
name implies, this form of tissue connects and provides support to various parts of the
body. Nervous tissue provides the body with a quick communication system. This tissue
is comprised of many neurons that synapse together to form a communication pathway.
Epithelial tissue allows the body to maintain homeostasis, mainly by providing protective
barriers and facilitating with water retention.

2.2

The Extracellular Matrix
In tissue engineering, researchers must be able to recreate an environment ideal

for supporting tissue growth. Part of this ability involves replicating or simulating parts
of tissues needed for cell attachment and other sustaining functions. Looking at one of
the individual tissue components, the extracellular matrix (ECM) is a three-dimensional
network of macromolecules in which smaller molecules, such as proteins, ions, and
water, are bound to [15]. This matrix provides both structure and support for the smaller
molecules. The ECM also provides a number of other functions, such as ion balance,
intercellular communication, and cell migration/adhesion. These various functions allow
for the growth of cells into tissue. This section will provide a brief describe several ECM
components that have been utilized by other researchers for cell patterning.
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2.2.1 Collagen
Collagen, which is the most abundant protein in the body, serves as an aggregate
to form various macrostructures, such as fibrils, basement membranes, filaments, canals
and sheets. Currently, there are 27 known types of collagen and proteins with collagenlike domains [15]. Of these 27 types, types I, II, and III are the most abundant forms of
collagen found in the body. Type I collagen is found mostly in connective tissue, such as
the skin, tendons, and bone; type III collagen is usually found with type I collagen. Type
II collagen can be found in cartilage [26]. These types of collagen are usually
synthesized by fibroblasts in precursor form, and then are processed once secreted into
the ECM [23]. Because of its affinity for cell attachment, tissue engineers have used this
component to provide specific attachment sites for cells used in their research. Roth et
al., for example, used collagen in a commercial printer and patterned collagen onto a
glass coverslip [47]. This technique created a pattern of cell attachment sites surrounded
by cell-repellant material, which would dictate where cells would attach.

2.2.2 Fibronectin
Fibronectin, one of the first ECM proteins to be characterized, is important in
attaching cells to the ECM. This molecule is rod-like in structure and is comprised of
three domain types that serially repeat [1]. Of the three repeatable domains, type III
fibronectin repeat is the most common domain. This domain contains a pep-tide
sequence arginine-glycine-aspartic acid, also known as RGD, which has been shown to
be an important feature of the domain’s binding site [1]. Utilizing this characteristic,
Klebe et al. have investigated the possibility of printing fibronectin onto substrates for
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patterned cell attachment [27]. Like research by Roth et al., Klebe et al’s research did not
include printing cells directly, but rather demonstrated that printers could be used to
influence and direct cell attachment by controlling where the cell attachment sites are.

2.2.3 Laminin
As its name might imply, laminin is found in basal laminae, which are thin “mats”
of ECM that underlie epithelial vessels and surround muscle and adipose tissue [1]. The
basal laminae serve as a separation layer between the previously mentioned tissues and
surrounding connective tissue. Many cells use the laminin as a sub-stratum for cell
migration [15]. Furthermore, laminin also is believed to promote neuronal growth.
Because of these features, researchers, like Turcu et al., have used laminin to serve as cell
adhesion sites, similar to research using collagen and fibronectin [57]. In their research, a
custom dispensing system was created that allowed the researchers to create patterns of a
laminin mixture on various substrates. As expected, neuronal cells adhered mainly along
the printed laminin pattern. Their results, along with Klebe and Roth, show that printers
have potential application for cell patterning.

2.3

Cells
The other vital components for engineering a tissue are cells. Living cells need to

be obtained in order to proliferate and differentiate into the desired cells. Once obtained,
these cells are cultured repeatedly to increase its population to a useable size. Because
the cells are alive, a proper environment must be maintained to maximize their longevity.
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Also, the cultured cells need to be occasionally assessed to ensure they are still usable.
This section will briefly review various types of cells currently in use by tissue engineers.

2.3.1 Autologous Cells
A number of cell types, categorized by their source, are used in tissue engineering
applications. Autologous cells are the most ideal cells to use for a few reasons. These
cells are obtained from the patient, usually through a biopsy. As a result, autologous cells
have the main advantage in eliminating any chance of an immunogenic reaction, since the
cells would express the patient’s own native surface markers. If the target tissue is
present and healthy, the patients own cells would be especially advantageous during
culturing. Cells from target tissues often are already differentiated, so chemical
stimulation with growth factors is not needed as much to induce desired tissue function.
This cell type has been successfully applied in tissue reconstruction. In research by Atala
et al., cells were obtained via biopsy samples from the bladders of several patients with
myelomeningocele [3]. Each individual’s cells were cultured, seeded onto a synthetic
bladder scaffold (which will be discussed in the next section), and cultured. The resulting
constructs were then implanted in their respective patient. Following surgery, most of the
patients saw improved bladder and bowel functionality. Furthermore, no significant
immunogenic reactions or rejection took place. Atala’s results demonstrated that
autologous cells can produce tissue with proper physiologic function and little rejection
or reaction.
While obtaining cells from the patient’s own target tissue would be an ideal
condition for culturing the same tissue, this method has some disadvantages as well.
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First, few cells are easily accessible for harvesting. Elderly patients or patients with
diseased tissue, for example, will most likely yield few, if any, healthy cells [21].
Furthermore, the cells may not be available at all if the target tissue was removed prior to
its need. Because these cells are obtained from target tissue, they are severely limited in
the types of tissue it can differentiate into. Due to these restrictions, other sources of
autologous cells have been researched for tissue engineering.

2.3.2 Stem Cells
Recently, stem cells have been used to generate larger quantities of tissue. Two
types of stem cells are currently used in research. Embryonic stem cells are, as its name
implies, obtained from embryos. Adult stem cells, on the other hand, are obtained from
various locations on an adult’s body. Unlike differentiated cells, stem cells are able to
differentiate into a number of cells. However, the difficulty in achieving this variation
depends on the type of stem cell.
Recently, five cell lines, derived from blastocytes in human embryos, were shown
to be pluripotent; in other words, they were shown to be able to differentiate into virtually
any cell type [21]. These embryonic stem cells (ESCs) were believed to exhibit
unlimited self-renewal. As a result, it could have been possible to culture almost any
tissue with this single cell line. However, the controversial use of this cell type made it
difficult to acquire funding; human embryonic stem cell research could not qualify for
National Institute of Health funding unless cells were obtained from embryos before
August 9, 2001 [62]. So while this cell type offered significant advantages, ethical issues
limited its use in research.
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As an alternative to ESCs, adult stem cells (ASCs) offer similar advantages but
without the controversy. Unlike ESCs, adult stem cells are not obtained from embryos,
but rather in tissues of living animals. For example, the most “common” adult stem cell,
mesenchymal stem cells (MSCs), could be obtained in multiple tissues, such as muscle,
cartilage, bone marrow, liver, and pancreas [21]. Despite the many locations, these cells
are incredibly rare within the body. Often, researchers are unable to obtain sufficient
numbers of ASCs needed for transplantation and cultivation. However, these rare cells
offer great potential. These cells are believed to exist in tissues in order to maintain
homeostasis. The cells become activated when tissue damage occurs. Like ESCs, ASCs
are also capable of self-renewal for the lifetime of the organism. More importantly,
ASCs are undifferentiated. Because of this trait, ASCs could be induced to differentiate
into a wide variety of cells. While was is difficult to prove that these cells were
pluripotent, many studies did support the belief that ASCs were at least multipotent. In
one study, for example, hematopoietic stem cells from one mouse were shown to
completely regenerate lethally irradiated hematopoietic systems of other mice [62]. This
amazing feat demonstrated the enormous potential that ASCs had for tissue engineers.

2.3.3 Progenitor Cells
Progenitor cells are technically intermediates of the stem cell, but have
significantly different characteristics. While stem cells are undifferentiated, progenitor
cells are “committed” towards differentiating along a certain pathway; in other words,
these cells are partially differentiated. When stem cells divide, at least one identical cell
is created, hence the self-renewing characteristic. On the other hand, when progenitor
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cells divide, both resulting cells are further differentiated. As a result, these cells
eventually result in a fully differentiated cell. However, since these cells initially have
different development pathways, progenitor cells are considered multipotent. For
example, researchers have used mesenchymal progenitor cells to grow muscle, bone [69,
37], cartilage [66], tendon [28], and vascular tissue. While these cells have the ability to
differentiate into many cell types, a lot of work involving biological, physical, and
chemical stimuli is required. Furthermore, like adult stem cells, progenitor cells are fairly
rare in the body. It is also difficult to distinguish between ASCs and progenitor cells,
though progenitor cells could be isolated using markers specific to certain cell
phenotypes.

2.4

Natural Scaffold Materials
Researchers are using the knowledge gained about the ECM to develop

techniques for synthetically engineering tissue. Currently, tissue engineers utilize a prebuilt, engineered scaffold, which is a three-dimensional structure that serves as a support
matrix for cells to restore, maintain, or improve tissue [70]. Both natural, ECM-based
and synthetic, polymeric materials are used to create these structures. One of the ways
the scaffold supports the cells is by providing an adherent surface for the cells to
proliferate and differentiate. In addition to an adherent surface, scaffolds may also
provide mechanical support to the cells. Furthermore, scaffolds must also allow for
nutrient and waste transport to sustain cells that migrate. Because these constructs are
eventually going to be implanted, researchers have to account for any immunogenic
reactions that a foreign material could induce. Although this project is dedicated to cell
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deposition, scaffolds will still be used by this system. Researchers are also investigating
the possibility of fabricating complex scaffolds using rapid prototyping techniques, which
will be explained in a later chapter. Because a future goal for this system will be the
ability to fabricate a scaffold and simultaneously seed cells during fabrication, the
following two sections will briefly discuss scaffold materials that could be used in such a
system.

2.4.1 ECM-based Polymer Scaffolds
Since the goal of the scaffold is to emulate parts of the ECM, natural ECM
components could be used as scaffold materials. For example, scaffolds have been
coated with hyaluronic acid to improve the scaffold’s cell-adhesion [30]. Although the
primary structure of this scaffold was fabricated using a synthetic polymer, the use of this
ECM component demonstrated that such a material could be integrated to add specific
characteristics. ECM components do not have to be relegated to just secondary scaffold
functions, however. For example, derivatives of hyaluronic acid have even been
successfully used as the primary scaffolding material for adipose precursor cells [20].
Collagen is another ECM component that has been used for creating scaffolds.
Collagen has a number of adhesion domains that provide a surface for cell attachment.
Because collagen promotes blood coagulation, it has been used as a scaffold for epithelial
cells, such as fibroblasts and keratinocytes [70]. Furthermore, this scaffold material has
been shown to allow rat hepatocytes to function. While a bioactive and biocompatible
material, collagen has numerous forms that lead to high variability. Also, a natural
component, it has a high degradation rate.
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2.4.2 Other Natural Polymer Scaffolds
Other natural materials have been used to create scaffolding for cells, each with
its own set of advantages and problems. Gelatin, which is derived from collagen, has
served as a natural scaffold material. To form gelatin, collagen is denatured into single
polypeptide chains. This material is water-soluble, and forms into a hydrogel through
temperature changes, which can then be stabilized for use as a scaffold through
glutaraldehyde cross-linking. As a hydrogel, gelatin has supported cells in orthopaedic
applications, such as differentiating adipose-derived stem cells into chondrogenicexpressing cells [70].
Alginic acid, also known as alginate, is a viscous, hydrophilic polysaccharide that
is found in the cell walls of brown algae. Alginate forms into a hydrogel when exposed
to divalent ions, such as calcium, allowing it to be used as a scaffold. While not a native
molecule in mammals, alginate has been shown to be biocompatible, as it does not
contain any RGD attachment sites needed for cell adhesion. Furthermore, the presence of
hydroxyl groups makes this molecule water-soluble. Despite the reduced likelihood for
adhesion, various cells have been shown to successfully bind to and function on alginate
scaffolds. For example, endothelial cells have successfully attached to custom alginate
scaffolds without the need for any additional chemical or surface modifications [7]. In
another study, rat hepatocytes seeded onto alginate sponges were able to secrete albumin,
which demonstrates the seeded cells were functioning in the in-vitro scaffold [18]. More
relevant to the scope of this project, alginate was used with a printer to rapid prototype a
scaffold [7]. Rather than dispense the alginate, however, Boland et al. dispensed the
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cross-linker onto a pool of alginate. This experiment suggests that in addition to seeding
cells, printers could also be used to build scaffolds.

2.5

Synthetic Scaffolds
Synthetic polymers offer a number of advantages over natural scaffolds. For

example, most natural polymers offer some functionality desired for the scaffold, but can
lack other vital characteristics. Synthetic polymers, on the other hand, can be engineered
to meet specific mechanical or chemical requirements for the scaffold. Furthermore,
most synthetic polymers undergo hydrolytic degradation, resulting in a more predictable
degradation rate [70]. However, issues with biocompatibility could arise because the
materials or its degradation products are usually not natural. Currently, over eleven
synthetic polymers have been researched for use as scaffolds. Only the more commonly
used polymers will be discussed below.

2.5.1 Polyesters
Polyesters make up the majority of synthetic polymers used in scaffolds. Poly(Llactic) acid (PLLA), is an example of a polyester. PLLA is a hydrophilic, crystalline
polyester that exhibits a high melting point and degradation rate, as well as resistance to
organic solvents. Furthermore, PLLA is also hydrophobic, making it appropriate for cell
adhesion. To control the degradation rate and mechanical strength, PLLA can be copolymerized with poly(glycolic acid). This copolymer is amorphous, resulting in a lower
degradation rate and mechanical strength when compared to PLLA [70]; degradation can
last anywhere from a few weeks to a few years by varying the ratio of PGA and PLLA
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[52]. Lactic acid, the byproduct of PLLA degradation, is biocompatible, as mammals
naturally break down this molecule during Kreb’s cycle.
This degradable polyester has been extensively used in tissue engineering
research. One study found that PLLA was able to support chondrocytes [70]. Another
study found that a PLGA scaffold had a lower inflammatory response than a collagenbased hydrogel, while also showing higher integration with the host body [48]. PLLA
has also been successfully engineered into an artificial anterior cruciate ligament [12].
Upon implantation, this artificial ligament induced relatively little immune reaction,
while showing signs of vascularization. Finally, more relevant to this project, a study by
Giordano et al. demonstrated how a printer could fabricate a PLLA structure [17]. These
research projects show that PLLA has great potential for future tissue engineering
applications.

2.5.2 Poly(ethylene glycol)
Poly(ethylene glycol) (PEG) is a linear polymer consisting of an ethylene oxiderepeating unit. As a hydrophilic molecule, this polymer can swell in aqueous solutions.
On the other hand, its linear structure results in low mechanical stability [70].
Furthermore, by itself, PEG is non-degradable. However, the polymer can easily be
cross-linked with other, degradable polymers to gain this ideal property. Another
property of the polymer is its resistance to protein adsorption [13]. While this property
may, at first, seem to be a disadvantage, researchers have used PEG to exploit this
specific feature. In a study by Sanjana et al., for example, PEG was coated onto a glass
coverslip to serve as a repulsive background [49]. A collagen-based mixture was then
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patterned, using an inkjet printer, over the PEG-coated coverslip to serve as an adhesive
for the cells. Neuronal cells were then plated onto the entire coverslip. Because of the
adhesive/repulsive substrates, the neuronal cells could only attach and migrate according
to the patterned adhesive substrate.

2.6

Bioreactors and Cell Seeding
In a traditional tissue engineering process, once a scaffold is fabricated and the

cells are ready, the cells need to be seeded onto the scaffold. This seeding occurs within
a device called a bioreactor, which maintains an environment ideal for cell proliferation.
The bioreactor achieves this environment in various ways. First, the scaffold is first
exposed to the cells to allow for adhesion. During this process, bioreactors control
temperature, gradients, and the size and shape of the scaffold. Furthermore, these devices
also allow for the transport of nutrients and waste. Depending on the type of bioreactor
used, additional forces could be added to stimulate certain characteristics while the cells
proliferate. This stimulation factors heavily into how the cells proliferate, migrate, and
differentiate. Therefore, for a traditional tissue engineering workflow, the bioreactor
must be carefully chosen for the desired tissue characteristics.

2.6.1 Static Culture
The simplest type of seeding technique is a static culture. While this technique is
not considered a bioreactor, it is worth mentioning for comparison. This seeding
technique has been widely used for tissues that require a fibrous or porous material [2].
In this basic seeding technique, the scaffold is placed in a culture plate and submerged
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with a cell medium suspension and placed in an incubator. Depending on the cell type
being used, this process could take from 24-48 hours to adequately seed cells. However,
while this technique is the simplest to implement, it also yields the poorest results. A
study comparing three seeding techniques found that static cultures had the worst surface
and matrix distribution / attachment, and poor metabolic activity. Furthermore, this
technique also gave the worst yield [8]. As a result of this low yield, more cells must be
used to seed an adequate amount of cells.

2.6.2 Spinner Flask Bioreactor
The spinner flask is the simplest form of bioreactors. This type of bioreactor
utilizes convection to seed and stimulate cells. To seed cells with this technique, the
scaffolds are threaded onto rods attached to the flask’s cover. The flasks are filled with
the cell suspension, which infiltrates the scaffold once the cover is attached. A magnetic
stir bar generates convection in the solution. This convection results in a turbulent eddies
around the construct, which is believed to improve nutrient transport and expose surfaceattached cells to shear forces [2]. While intended to generate a homogenous cell
distribution, the shear stresses are varied, resulting in a non-homogenous distribution.
Ironically, while intended to maintain a well-mixed system, this dynamic seeding type
actually performs worse than a static culture [8].

Figure 2.1 Schematic drawing of a spinner flask bioreactor [8]
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2.6.3 Rotating-Wall Vessel
The rotating-wall vessel has become the most widely used bioreactor design for
bone, cartilage, and other tissues. This vessel, originally designed by NASA, is
comprised of two concentric cylinders. The outer cylinder, which is linked to a rotor,
houses the scaffold and cell/medium mixture. This outer cylinder rotates until the
centrifugal forces negate gravitational forces. The inner cylinder, which does not rotate,
is permeable for gas exchange. A huge advantage of the rotating-wall vessel is uniform
tissue growth with no specific orientation; this characteristic is a result of the
microgravity environment generated by the centrifugal forces. Furthermore, a rotatingwall vessel can create an almost uniform laminar flow with a consistent shear. These
fluid flow characteristics can facilitate with establishing a homogenous cell distribution
within the scaffold [2].

Figure 2.2 Example of a NASA-designed rotating-wall vessel [14]
2.6.4 Perfusion Bioreactors
Unlike spinner flasks and rotating wall vessels, flow perfusion bioreactors utilize
no moving parts in the bioreactor chamber. In a perfusion bioreactor, the enclosed
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scaffold is exposed to a continuous fluid flow. Unlike the other bioreactor systems, this
flow can be distributed between the scaffold, the surrounding environment, or both.
These characteristics can allow for a controllable flow, which can improve nutrient
transport. Furthermore, internal flow can expose the luminal surface to shear forces,
which can facilitate the migration and differentiation of endothelial cells [2].

2.6.5 Bioreactor Design Considerations
While the three bioreactors mentioned above have been used to culture scaffolds,
different cell types require different environments. As a result of this necessity, custom
bioreactors are often developed to best mimic the native physiological environment. At a
minimum, the bioreactor must maintain a temperature of 37ºC, humid atmosphere with a
5% CO2 composition [2]. During the entire operation, the bioreactor must remain sterile.
This requires a way to change culture aseptically and easily assemble the system. In
order to induce the desired cell differentiation, the bioreactor needs to supply similar
physiological stimuli to the scaffold. These stimuli could include any of the following:
growth factors, pulsatile flow, compressive/tensile/ forces, and torsion [2].
When scaling up a bioreactor, cell distribution becomes a major concern. The
bioreactor comparison study demonstrated that a bioreactor’s effectiveness at establishing
a homogenous cell distribution directly affects how well the cells attach and perform [8].
As the scaffold size increases, care will need to be taken to ensure that the bioreactor
design will be able to effectively transport cells and oxygen to all parts of the structure.
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2.7

Dealing With Limitations of Current TE Techniques
While traditional tissue engineering has produced positive results in generating

tissue, several disadvantages limit its full potential. First, cell distribution is often not
uniform. With traditional seeding, a uniform distribution is necessary to ensure
homogeneity across the entire construct. Without this proper uniformity, a part of the
tissue construct may not differentiate or function correctly because it did not receive a
specific cell. On a similar note, while the need for a uniform distribution is important,
current techniques cannot easily place different cell types into specific locations on the
scaffold [6]. Spatial distribution is important for proper intercellular communication.
For example, functions such as wound healing and homeostasis require interactions with
neighboring cells. Because current techniques cannot specifically place cells, the adhered
cells will need to migrate to their proper locations. The time for these cells to migrate
can as long as several months, which could eliminate critical patients from receiving vital
tissues.
While the issues listed above are all mainly due to cell seeding techniques,
scaffolds used in traditional tissue engineering also suffer from limitations. For example,
PLA scaffolds have characteristically rigid structures. While this scaffold would be
appropriate for tissues like bone, tendons, and ligaments [70, 12], this rigidity would not
be appropriate for contractile tissues, such as cardiac tissue. Furthermore, traditional
scaffold fabrication methods, such as casting and molding, often produce tissues that lack
vascularization. Vascularization is a vital characteristic if larger tissues are to be
constructed [6]. While most researchers are working to resolve these problems to
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continue using traditional techniques, some researchers are looking towards other
techniques and technology to bypass these issues.
By including the cell depositing process with the scaffold creation process, this
project aims to move task of cell seeding away from the bioreactor and accomplish the
task during fabrication. Seeding the cells during scaffold fabrication should reduce
problems with cell distribution, as the cells would be placed in its proper location before
the scaffold is complete. Because of this, the need for cell migration should be reduced,
leading to faster culture times. Although no longer responsible for seeding cells, a
bioreactor would still be needed with a cell printer. However, a static culture would no
longer be appropriate for a printed-cell scaffold, as this method was used to seed cells.
Spinner-flask, rotating-wall and perfusion bioreactors could still be used to impart
physical and chemical forces to facilitate with tissue growth.

21

3.0

RAPID PROTOTYPING IN TISSUE ENGINEERING
Prior to the advent of computers, designs were visualized by creating scale

models. This often was a time consuming process, and only provided a visual
representation of the design. The computer somewhat alleviated this problem by
allowing for quick 3D visualization of a design. While this satisfied many architects,
engineers also wanted a way to quickly create a physical model that could simulate or
fulfill the physical function of their design. Methods of fabricating models, such as
casting, molding, and milling, were often slow and required expensive materials. Rapid
prototyping provided engineers and architects a relatively cheap and quick way to
fabricate models for visualization and functional verification.
Despite its origins in architectural modeling, rapid prototyping technology has
begun to provide tissue engineers with a number of potential solutions for problems
encountered when trying to create larger, more complex tissues. The most significant
issue that rapid prototyping tried to resolve was the issue of vascularization. Nutrients
needed to reach every part of the growing tissue, otherwise necrosis occured. To
accomplish this diffusion, a complex internal vascular network was required. This
network can only be achieved by directing tissue growth with the scaffold. Traditional
molding techniques could not build complex porous networks because the mold would be
embedded in the interconnecting network. Casting techniques, while somewhat able to
integrate the pores, required a lot of time and material to fabricate the casts. Rapid
prototyping systems, on the other hand, built models layer-by-layer. This difference
allowed for the complex internal pore network to be easily constructed. Furthermore, the
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build-on-demand nature of rapid prototyping provided researchers the potential to easily
create custom architectures, based on a patient’s own needs.
Related to the issue of nutrient supply, optimized tissue growth is a function that
can be potentially aided by using rapid prototyping techniques. Traditional tissue
engineering techniques relied on random placement of cells and cell migration in order to
generate tissue. To accomplish this task, a tissue scaffold was usually placed in a
bioreactor to seed the cells. While sufficient for seeding single cell-types, this technique
may not be efficient when trying to engineer multi-cellular tissue, as similar cell types
usually group together in tissues. Although tissue has been engineered using this
technique, researchers could experience difficulty when trying to grow larger tissue.
With larger constructs, cells may have a harder time diffusing deep within the complex
network, leading to an improper distribution of cells. Because rapid prototyping systems
build a structure layer-by-layer, cells could be strategically integrated into a scaffold as it
is being fabricated. This on-demand characteristic could allow for 3D-specific placement
of cells, reducing the need for cells to migrate to its desired location on a scaffold.
Depending on the complexity of the RP system, multiple cell-types could be strategically
placed for optimal tissue growth.
Currently in the rapid prototyping market, over sixteen RP systems are available.
For tissue engineers, however, at least six of these systems have been investigated for use
with tissue engineering applications. While all six of these systems utilize a layer-based
construction model, they implement this 3D construction using different methodologies.
In this paper, these systems will be classified into two primary categories: 3D dispensing
systems and particle-bonding systems.
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3.1

3D Dispensing Systems
Three-dimensional (3D) dispensing systems are a class of rapid prototyping

devices that primarily extrude a semisolid material. Following extrusion, this material
eventually hardens and binds to the previous layer. Successive layers are then extruded,
allowing for the formation of a 3D object. The ability of the extruded material alone to
support itself when constructing 3D structures is this system’s primary advantage.

3.1.1 Direct Inkjet Printing
Despite its name, direct inkjet printing can be considered more as a melt
deposition system. A direct inkjet, available through companies such as 3D Systems,
dispenses fluid in a discontinuous fashion, much like a traditional inkjet printer. Because
the system does not rely on a continuous stream of fluid, multiple nozzles and heads can
be used. Unlike standard inkjet printers, however, direct inkjet printers utilize a wax-like
thermoplastic material as the “ink.” Therefore, like fused deposition modeling, the
dispensed material hardens, allowing successive layers to be built on top of itself.
This technology has not been extensively utilized in tissue engineering
applications for a few reasons. First, material choices were severely limited with direct
inkjet printers. The polymers used with 3D Systems’ implementation of the technology,
for example, have not been tested for biocompatibility. Second, heat generated by the
system may be harmful to the cells. A constant temperature must be maintained to
maintain the thermoplastic material in a semi-fluidic phase. Temperatures exceeding
37ºC could put the cells at risk of dying; to contrast, some direct inkjet waxes have melt
temperatures exceeding 100ºC [35]. Finally, models built using this technique require
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support structures, usually made of waxes of different solubility than the main material.
Because of this characteristic, extra processing is required to eliminate the supports,
making it not only difficult to create the complex internal structure, but also nearly
impossible for simultaneous cell-seeding. Because of these limitations, direct inkjet
printing has been relegated primarily to creating molds for casting with bioactive
polymers [45].

3.1.2 Fused Deposition Modeling (FDM)
The most common variation of a melt deposition system is fused deposition
modeling (FDM). This technology, commercially available through companies like
Stratasys, utilizes a continuous flow of material. In a typical FDM system, a polymer
monofilament is fed into the extrusion head. A heater within the head melts this
monofilament into a viscous semisolid. The melted thermoplastic is then extruded
through the head’s nozzle onto the build platform or previously deposited layer. To
allow for binding of successive layers to form a solid, the entire build platform is
enclosed within a heated, temperature-controlled cabinet.
Due to the continuous flow of the polymer, FDM systems typically operate using
vector-based operations. Each consecutive layer, as well as each deposited material, can
be deposited in a different direction and gap spacing. By controlling these two factors, a
complex, honeycomb-like internal structure can be formed. Furthermore, the ability to
change the direction of successive layers can strengthen the structure. The zigzag pattern
to create a solid layer can act much like a layer of fiber, able to resist forces in only one
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direction. By changing the direction of each additional layer, the structure becomes more
able to resist forces in other directions.

Figure 3.1 Schematic diagram of a typical FDM system [72]
A few issues limit this technology’s use in tissue engineering. First, although the
system allows for variable pores, it cannot create consistent pores in all three dimensions.
As material overlaps in consecutive layers, pores in the xy-plane can become partially
occluded. Second, while the dispensed polymer alone can achieve material buildup,
support structures are still required to ensure the integrity of the model [4]. However,
compared to direct inkjet printers, not as much support material is required. As a result, a
complex internal structure is still possible. This possibility allowed researchers like Zein
et al. to fabricate poly(caprolactone) scaffolds, which could have been used with hard
tissue cells, such as osteoblasts [72]. Unfortunately, other desired functions, such as the
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ability to fabricate soft tissue scaffolds and simultaneous cell integration, are more
difficult to achieve for a few reasons. First, solvents are required to free the construct
from its support. These solvents are often toxic to cells. Second, the materials need to be
pre-processed into a filament, which could make the process of integrating cells difficult.
In addition, the low water content required to create a filament means that hydrogels,
which are commonly used to support soft tissue cells, cannot be fabricated using FDM.
Finally, just like direct inkjet printing, the dispensed material relies on heat to melt the
material. Although Zein et al. were able to use a biocompatible material like
poly(caprolactone), they would not have been able to simultaneously integrate cells using
the FDM system, as the material had a melt temperature of 60ºC [72].

3.1.3 3D Bioplotting
Recently, researchers have been investigating whether a newly developed form of
3D dispensing could resolve a couple of issues with the previous 3D dispensing systems
discussed. Like the other dispensing systems, a 3D bioplotting system dispenses a
viscous fluid. However, unlike the solid platform that is used by these other systems, 3D
bioplotters dispense into a liquid medium. This medium, which must match the density
of the dispensed material, provides a neutral buoyancy effect for the model being
constructed [45]. As a result of the force reduction on the model, the need for support
structures is eliminated. This elimination therefore allows for the construction of a
variable internal pore network, much more complex than what is achievable by FDM.
3D bioplotting also reduces the problem of materials. Other 3D dispensing
systems, like FDM or direct inkjet printing, are severely restricted in materials options.

27

FDM systems, for example, cannot process many biodegradable polymers due to its very
narrow processing window; currently, poly(caprolactone) (PCL) is the only known
degradable polymer that works with FDM [45]. Because of the nature of 3D

Figure 3.2 Schematic drawing of a typical 3D bioplotter [31]
bioplotters, a wide variety of materials, including polymers such as PLGA and PCL,
thermoset resins, and even cement, have been shown to be compatible with the system.
For instance, a study by Rücker et al. created a PLGA scaffold with a 3D bioplotter [48].
In their study, the bioplotted PLGA scaffold elicited a weak immune response and
showed signs of vascularization after implantation. Furthermore, because of its aqueous
build environment, bioactive materials, such as proteins, have also been used with 3D
bioplotters [45]. For example, in addition to the PLGA scaffold discussed above, Rücker
et al. used the same 3D bioplotting system to fabricate a scaffold containing collagen,
chitosan, and hydroxyapatite [48].
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3.2

Particle-Bonding Systems
As its name implies, this RP technology bonds or fuses selected particles in order

to form a solid. Unlike 3D dispensing systems, which dispense the build material onto an
empty platform, particle bonding systems start with the build material already on the
build platform. Although present on the build platform, this material is unprocessed and
unbound. A head then passes over the material to bind material in a desired pattern.
Following completion of the layer, a fresh layer of unbound material is placed over the
bound material, and the process repeats.
This RP technique shares similar advantages with 3D bioplotting. Like 3D
bioplotting, the structure is surrounded by a supporting medium. However, rather than
using a support material that differs from the build material, particle-bonding systems use
a single material that serves as both build material and support. As the structure is built
in a particle bonding system, the surrounding unbound material continuously supports it.
Therefore, like 3D bioplotters, structures built with particle bonding systems do not
require additional support structures. Also due to the lack of support structures, particlebonding systems are capable of creating complex internal structures.
Three of the most common particle-bonding systems are defined below.
However, stereolithography is technically not considered to be a particle-bonding system
because of the material choice. Because it shares many of the same fundamentals as a
traditional particle-bonding system, it will be included in this category. While all these
systems share the same advantages described above, they each have their own unique
advantages and disadvantages as well.
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3.2.1 Stereolithography
Stereolithography (SLA) is a liquid-based system that shares some characteristics
of a traditional particle-bonding system. Typical SLA systems, available from companies
such as 3D Systems, house a photo-curable resin in the build space. To form a solid, the
submergible build platform is first raised until only a very thin layer of fluid covers the
platform. A mobile mirror then directs a UV laser onto the fluid. Any fluid exposed to
this UV laser would undergo photo-polymerization, causing a solid to form. Upon
completion of the layer, the elevator drops the structure enough to cover the cured layer
with a fresh coat of liquid resin, and the process repeats.
While this method shares a number of the same advantages as a 3D bioplotter, it
has a serious disadvantage, especially with respect to tissue engineering applications. A
3D bioplotter is compatible with a wide variety of materials, ranging from melts,
solutions, reactive resins, paste, cements, and biologic materials. SLA systems, on the
other hand, are severely limited in material options. Current SLA devices are currently
restricted to photo-reactive resins. Furthermore, the available resins are all toxic.
Despite these disadvantages, SLA has been used for scaffold production. In one study by
Chu et al., a lost-mold process was developed around SLA [29]. In their study, the
standard, commercial epoxy resin was used. Rather than fabricate the scaffold directly,
the SLA system was used to fabricate a negative mold of the intended scaffold design.
An organic suspension, which consisted of hydroxyapatite and acrylic binders, was then
cast into the mold and cured. This solid then underwent pyrolysis and sintering to
remove the epoxy and acrylate, as well as strengthen the scaffold; the group did note,
however, that a miniscule amount of binder did remain after the procedure. After all this

30

post-processing, the group was able to obtain a scaffold with channels as fine as 366-!m,
very close to the 250-!m lower limit of the UV laser [29]. Subsequent research by the
group showed that their scaffold had an elastic response similar to coralline
hydroxyapatite. Furthermore, in-vivo testing demonstrated that osteogenesis was taking
place within the scaffold [9]. Although some binder material does remain, Chu et al.’s
work did demonstrate the possibility of using SLA for bone scaffold research.

Figure 3.3 Hydroxyapatite scaffolds built using SLA technology [10]

3.2.2 Selective Laser Sintering
Selective Laser Sintering (SLS) is a traditional particle-bonding system that
utilizes a CO2 laser beam [4]. Unlike SLA systems, SLS systems house a bed of unbound
powder. An elevator platform is raised to the top of the powder bed, and a roller ensures
that a flat layer of powder resides at the top. To form a solid, a deflected laser beam
selectively scans over the desired location. The laser beam causes the powder’s
temperature to rise to its glass-transition point, causing it to fuse with neighboring
particles. Following completion of the layer, the platform descends slightly, the roller
dispenses a new layer of powder over the completed layer, and the process repeats.
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SLS technology has its own unique characteristics. Because the particles are
fused together, structures created using this method can withstand greater forces than
other structures. Many SLS systems also allow the end-user to fine tune the
microstructure. By controlling the laser’s exposure density, scan speed, and temperature,
the quality of sintering can be adjusted. Because binding is achieved by the use of the
laser’s energy, additional solvents are not required. However, this RP method also has a
few limitations. Like SLA, SLS systems have limited material options. The minimum
pore size also depends on the powder’s particle size, which is usually around 50 !m in
diameter [4]. Because of the high temperatures involved when using the laser, the system
is restricted mainly to thermally stable polymers. This high temperature also eliminates
the possibility of simultaneously depositing cells.

Figure 3.4 Schematic diagram of SLS workflow [55]
Although the system was not capable of depositing cells, SLS was still used in
tissue engineering research. Its use, however, was mainly restricted for creating
scaffolds. In particular, researchers investigated whether the technology could be used to
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develop bio-ceramic scaffolds for use in repairing bone defects [55]. In one study,
hydroxyapatite particles were coated in poly(methylmethacrylate), which served as the
primary binding particle [33]. Unfortunately, this procedure involved the use of an
organic solvent, which was undesirable for tissue engineering. However, it did
demonstrate that a biomaterial could be successfully integrated into a scaffold created
using SLS. Another study eliminated the need for solvents by using a powder blend
consisting of hydroxyapatite and polyetheretherketone (PEEK). PEEK was a
thermostable polymer that exhibited a low amount of cytotoxicity [55]. This study
demonstrated that SLS, like SLA, could be used in bone tissue engineering applications.

3.2.3 3D Printing
Not to be confused with direct inkjet printing, three-dimensional printing (3DP),
developed in 1989 at the Massachusetts Institute of Technology [4], is a powder-based
particle-bonding system that involves the use of inkjet heads [45]. Like SLS systems, a
3D printer utilizes a roller to spread and compact powder over a descending build
platform to create a thin powder layer. Typical 3D printers, available from companies
like Z Corp, use a starch-based powder. However, instead of using a laser to fuse
particles together, 3DP employs inkjets to bind particles. The inkjet cartridges, most
often taken from commercial desktop printers, are loaded with an aqueous binder
solution, and then dispense ink over selected areas to bind the powder. Once a layer has
been exposed to the binder fluid, the roller spreads another layer of powder, and the
process repeats.
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Figure 3.5 Schematic diagram of 3DP workflow [25]
Of all the particle-binding systems, 3DP offers the most flexibility for materials.
Looking at the previously mentioned systems, SLA can only use reactive, toxic resins;
SLS is slightly more flexible, being restricted to thermostable polymers. 3DP, on the
other hand, can use materials based on starch, sugars, polymers, plaster, metals, and even
ceramics [45]. A caveat of this flexibility is that these materials must be available in
powder form. Like SLS materials, the resolution and porosity of a 3DP-created structure
is heavily dependent on the powder’s particle size. On average, a 3DP system is able to
achieve a 300-!m resolution, with pore sizes in the range of 45-150 !m in diameter [69].
While this places the porosity achievable with 3DP on the same level as SLS, it falls
short of the larger 250-1000 !m pores that can be created using 3D dispensing
technologies, such as FDM [4].
3DP does have its own set of problems. One disadvantage of 3DP is that solvents
often are used with the system. Usually, organic, though toxic, solvents serve as the
binder. In addition to this disadvantage, extra post-processing is required to strengthen
the structure after printing, which often also involves toxic substances. This need for
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toxic chemicals, however, was not always the case. In one study, for example, Lam et al.
were able to develop a starch-based powder that was able to be bound using just distilled
water [69]. Compared to other organic solvents, distilled water was much more
biocompatible. This study served as a perfect example of the flexibility that the RP
method offered, even with the binder solution.
Because of its great flexibility and relative low operating costs, 3DP has been
extensively used in tissue engineering, especially in scaffold creation. In the previous
example, Lam et al. not only developed a more biocompatible powder/binder
combination, but also successfully created scaffolds using their materials [29]. To further
the strength of the scaffold while maintaining biocompatibility, the group infiltrated the
scaffold with a PLLA and PCL copolymer. The group observed a maximum of 12%
shrinkage following post-processing, with circular pores causing the greatest reduction.
Not surprisingly, scaffolds infiltrated with a higher volume of copolymer were shown to
exhibit more water resistance and stiffness.
In addition to using standard 3DP techniques, Tay et al. demonstrated how a
unique step in their workflow aided scaffold creation. In their study, PCL and poly(vinyl
alcohol) (PVA) powders, mixed in various proportions, were used as the powder bed.
Interestingly enough, PVA, this time in a liquid state, also served as the binder. In the
post-processing step, the scaffold was immersed in de-ionized water. PVA, a watersoluble particulate, leeched out when immersed in de-ionized water [56]. As a limitation
of this method, the scaffold needed to be heat-treated at 65ºC in order to ensure that the
scaffold could maintain integrity when immersed for some time [56]. While the heat
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treatment made simultaneous cell seeding impossible, this unique process demonstrated a
novel method of creating the complex pore network needed in scaffolds.
Kim et al. showed how viable printed scaffolds were with cells [25]. In their
study, PLGA powder was combined with sodium chloride particles to serve as the
powder bed. They fabricated a cylindrical construct with interconnected longitudinal and
radial channels. In a technique similar to Tay et al., the salt particles were leeched out
using distilled water, facilitating the creation of the interconnected channels. Following
this salt leeching, the scaffold was then soaked in culture medium, statically seeded with
hepatocytes, and finally perfused in a bioreactor. Their tests showed successful
attachment and migration of the hepatocytes. Lam, Kim, and Tay’s results demonstrated
that 3DP technology could be a potentially be adapted for tissue engineering.

Figure 3.6 Scaffolds created using 3DP and salt leaching [25]

3.3

Choosing the Most Appropriate RP System
Almost all of the systems described above have been used for some application of

tissue engineering. In terms of scaffolds, everything but direct inkjet printing could have
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been used. However, when considering the future ability to fabricate a biocompatible
scaffold using the same device, SLA became less appropriate due to the toxic resins used.
Since cells were going to be dispensed with this system, the dispensing system had to be
“gentle” to the cells. Some ideal characteristics to achieve this function included a low
operating temperature and easy integration of cells with the system. These requirements
eliminated FDM because of the processing required for the printing materials, as well as
the heating element to melt the thermoplastics. SLS was also eliminated because of its
high-energy output required to fuse the substrate. After considering all these
requirements, only 3DP and 3D bioplotting were left as viable options.
While both systems featured a substrate-supported build model, the technology
behind 3DP was chosen for this project for a few reasons. First, the department already
had access to a Z-Corp 3DP system, so it could be used as reference for adding scaffold
fabrication abilities to the system in the future. In terms of materials, a 3DP potentially
worked with a greater set of materials, compared to 3D bioplotting. 3D bioplotters
required the substrate to match the density of the printed solution. A 3DP, on the other
hand, required that the powder bind with the printed solution. Finally, since the
surrounding environment consists of air, a 3DP inkjet did not require a complex setup; in
comparison, a 3D bioplotter could have required the use of a needle and higher pressures
in order to dispense into the fluidic environment. Although the system could easily be
adapted for 3D bioplotting functionality, a 3DP-like approach was chosen for simplicity.
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4.0

INKJET TECHNOLOGY AND ITS ROLE IN CELL PATTERNING
The rise of rapid prototyping has initiated research into using various techniques

to generate the complex 3D models. Inkjet technology, currently used in 3D Printing,
offers a number of advantages in rapid prototyping. It is widely used due to its low cost
and high availability. Furthermore, its simplicity leads to lower production costs. The
ability to use virtually any fluid allows for great flexibility in materials selection.
Because of the abundance of tissue engineering research using this technology, as
well as the simplicity involved in its use, an inkjet-based system was investigated in this
project. Utilizing this technology for scaffold development and cell deposition, however,
requires further study of the various types of inkjets and their characteristics. Therefore,
this chapter will provide an overview of the various forms of inkjet technologies that
have been considered for tissue engineering applications.

4.1

Continuous Inkjet Technology
Continuous inkjets are one major classification of inkjet technology that is still

used today. This form of ink jetting dateed back to 1878, when Lord Raleigh first
described the method to break streams into a series of droplets [46]. This technology
utilizes a high-pressure pump to rapidly propel fluid from a reservoir through a tiny
orifice, creating a high-velocity, continuous flow of fluid. A piezoelectric crystal then
oscillates within the nozzle to create a pressure wave pattern, which disperses the
continuous stream of fluid into droplets. To control its direction, the droplets pass
through an electrode, charging the droplets. Deflection plates then direct the charged
droplets either to the print surface or to a collection gutter for recycling.
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Figure 4.1 Schematic illustration of binary-deflection continuous ink jet [32]

While continuous inkjet technology could have allowed for rapid deposits of
fluid, a couple characteristics of this technology made the system unfeasible for handling
cells. The primary problem with continuous inkjets was the constant exposure of the
fluid to the environment. This constant fluid flow could have potentially resulted in
contamination if the print environment was not adequately sterilized. Another issue with
the system was potentially low accuracy. With a continuous inkjet, the placement of the
droplet relied solely on how well the electromagnetic plates deflected the fluid.
Performing this deflection would have required a complex hardware setup. To reach
micron-level accuracy, even more complex hardware could have been required. The
nature of the droplet position could also have been affected by the molecular properties of
each individual droplet. Droplets that were charged differently could have reacted in
different ways to the deflection plates. Therefore, consistency between droplets would
have become an issue.
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4.2

Drop-on-Demand Inkjets
The other major classification of inkjet technology is known as drop-on-demand

(DoD) inkjet technology. Unlike continuous inkjet technology, which has a constant
fluid flow into a reservoir until deflected onto the print surface, drop-on-demand inkjets
dispense drops only when required. This difference results in fewer complex components
required to operate. However, because an individual nozzle can only dispense a single
drop at a time, many nozzles are required to reach the same rate of fluid flow as a
continuous inkjet.
When considering applications in cell depositing, DoD inkjets should be the more
appropriate choice of technology. As previously mentioned, continuous inkjets would
have constantly exposed all the fluid to the print environment. Because drops in a DoD
inkjet dispense on demand, only the fluid that comes in contact with the print surface
would be exposed to the atmosphere. As a result of this difference, the risk of
contamination should be significantly reduced. Furthermore, DoD inkjets should be
more accurate. Unlike continuous inkjets, DoD inkjets only dispense fluid directly below
the nozzle. This limited range of direction would reduce complexity in achieving highresolution patterns, currently as accurate as 350-!m [47]. This accuracy would only be
limited by how precise the positioning motors could move and how small of a droplet the
inkjet could form.
Two types of drop-on-demand inkjet technology are commonly used today. Both
dispense fluid by the drop, but perform this task using different methodologies. A third
technology, which was used for this project, operated on a completely different set of
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principles. However, due to similar characteristics with the more common forms of
inkjets, this third form was also classified as an inkjet.

4.2.1 Thermal Inkjets
The first of these drop-on-demand implementations is a thermal inkjet, not to be
confused with thermal wax inkjets (dye sublimation). This system, first commercialized
by Hewlett Packard in the 1970s, utilizes heat to eject fluid from its head. Fluid is first
loaded into a chamber in the inkjet head. A thin resistor then heats up a small amount of
the fluid (less than 0.5%) until a gas bubble is formed [5]. This bubble then expands until
a drop is forced out of the nozzle. New fluid fills in the chamber, and the process repeats.
Two main variations of this system currently exist. One version, called a roof-shooter,
places the heater element above the orifice. A side shooter, on the other hand, places the
orifice along the side, with the heating element along part of the wall [32].

Figure 4.0 Schematic diagram of (a) roof-shooter and (b) side-shooter thermal inkjets [32]

Thermal inkjets have been used to dispense proteins. A study by Roth et al. used
a collagen solution with an old Canon thermal inkjet [47]. In their study, a glass
coverslip was coated with agarose, which functioned as the substrate. The thermal inkjet
then printed the collagen in various patterns on the substrate. Following printing, the
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coverslip was placed in a well and seeded with neuronal cells and smooth muscle cells
and incubated for a number of days. Initial observations, performed by light microscopy,
showed a number of unattached cells. However, by the fifth day of incubation, cells that
did adhere in the printed pattern began to reach confluency. Interestingly enough, the
group noted that higher densities of cells when seeding resulted in a shorter lifespan for
the attached cells; lower densities, on the other hand, lasted longer, but also took longer
to reach confluency. These results demonstrated that ECM components could potentially
be used with thermal inkjets.
Thermal inkjets have also been used to deposit a variety of actual cells. Xu et al.
attempted to deposit ovary and neuromuscular cells [68]. This study reversed the ink and
substrate that were used by Roth et al. in the previous study. In Xu’s study, ovary and
motoneuron cells were loaded into a standard HP cartridge and inkjet printer, while agar
and collagen were pre-coated onto a glass coverslip to serve as the substrate. Following
printing of the different cells, the coverslip was incubated in culture medium. Like with
Roth’s results, many cells were observed to be undifferentiated or dead after one day of
incubation, but the remaining cells were able to show signs of proliferation after several
days. The motoneuron cells, in fact, showed signs of differentiation after only 5 days in
culture. Both Roth and Xu’s successes demonstrated that thermal printing was a viable
option for inkjet-based tissue engineering.

4.2.2 Piezoelectric Inkjets
Canon and Epson currently use the other major drop-on-demand technology,
known as piezoelectric (piezo) inkjets. Unlike thermal inkjets, piezo inkjets do not use
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heat to dispense droplets. In a typical piezo print head, one side of the fluid chamber
contains a diaphragm. This bendable diaphragm is connected to a piezoelectric ceramic
[32]. Once the chamber is loaded with fluid, an electric charge is applied to the piezo
ceramic. This charge causes the piezo ceramic to change its conformation, resulting in a
volume decrease inside the fluid-filled chamber. By decreasing the chamber volume, the
chamber pressure increases, causing the fluid in the chamber to flow out of the one-way
nozzle.

Figure 4.2 Schematic illustration of (a) bend-mode, (b) push-mode, (c) shear-mode piezo inkjet [32]

Three variations of this form of drop-on-demand inkjet technology exist;
however, these varieties operate on the same principle of volumetric changes to dispense
fluid. In a bend-mode piezo ink-jet, as shown in Figure 4.2a, the piezo ceramic,
diaphragm, and fluid chamber are aligned in a laminar fashion. An electric charge,
applied parallel to the polarization of the ceramic, causes the material to bend towards the
chamber. This action forces the diaphragm inward as well, decreasing the chamber’s
volume. A push-mode piezo inkjet (Figure 4.2b) operates in a similar fashion. However,
in this variation, the piezo ceramic is in the form of a rod, where one end of the rod is
attached to the diaphragm. The applied charge causes the rod to expand, pushing into the
diaphragm, causing fluid ejection. Unlike the previous two variations, a shear-mode
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piezo inkjet (Figure 4.2c) contains no diaphragm. Instead, the piezo ceramic itself forms
an active wall that comes in contact with the fluid. Electric fields, this time perpendicular
to the piezo ceramic’s polarization, cause the material to shear, deforming against the
chamber [32].
Researchers have investigated whether piezoelectric inkjets could be used for
printing human cells. Saunders et al. tested human fibroblasts with a single piezo inkjet,
rather than a commercial inkjet system [51]. Unlike the studies performed by Roth and
Xu, Saunders did not use any pre-fabricated substrate; instead, the cells were directly
printed into uncoated well plates. To analyze the effects of changes to the printing
process, Saunders also varied some controllable conditions, such as excitation voltage
and rise time. A doubling in voltage resulted in cell viability dropping from 98% to 94%.
The group could not find any statistical significance in changes to the voltage rise time,
however. Despite the slight decrease in cell viability, Saunders et al. demonstrated that
piezo inkjets could be used to safely deposit cells.
Another study, following earlier research by Sanjana et al. [49], attempted to use a
custom-designed piezoelectric dispenser with neural cells. In Gustavsson et al.’s study,
cells from mouse dorsal root ganglia were fed through a proprietary microdispenser [19].
This microdispenser, modeled after a push-mode piezoelectric jet, was claimed to
dispense drops with 6-8 !m of precision. In addition to testing the inkjet design, the
study also included variations to platform warming, solution density, and print surface.
The group observed that patterning on glass cover slips was more difficult than printing
on plastic culture plates, due to frequent droplet aggregation on the cover slips. To
compare the effect of temperature on the cells, the group integrated a 30ºC heater on the
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platform. When using the heater, lines printed ended up fairly smooth; non-heated lines,
on the other hand, appeared ragged, due to spreading of the solution. When the densities
of both the neurite solution and a bovine serum albumin (BSA)/laminin solution were
varied, the group noted that a solution with increased density printed out as a thin line,
due to an increased viscosity. Neurite growth was shown to follow the printed pattern at
this high density. With lower densities, the lines of printed solution came out thicker due
to the lower viscosity; neurites in this scenario did not follow the pattern of BSA/laminin.
Gustavsson et al. successfully demonstrated that a piezo dispenser could not only
dispense neural cells, but also direct their growth.

4.2.3 Solenoid-based Inkjets
Solenoids have been utilized for more industrial inkjet designs. This form of
inkjet technology operates in a different fashion than traditional inkjets. In a solenoidbased inkjet printer, such as the one utilized in this project, no sudden physical changes
affect the printer fluid to induce droplet dispensing. Instead, a constant pressure provides
the driving force behind fluid flow. This gradient could be established in different ways.
For example, ink could be loaded into a syringe-like reservoir and become pressurized by
physically moving a plunger. Unlike a piezo print head, the pressure gradient in a
solenoid-based inkjet is continuously applied throughout the entire ink reservoir. To
dispense a drop, a current is quickly pulsed through the solenoid valve. As the current
passes through the solenoid, a magnetic field is induced. A plunger, normally keeping
the valve closed, moves toward this magnetic field, thus opening the valve. Once the
valve is open, the previously established pressure gradient forces fluid to eject out.
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These solenoid-based inkjets, available through companies such as The Lee Co.,
offer a couple of advantages over the thermal inkjets. The main problem with thermal
inkjets is the relatively high-temperature, although quick, bursts experienced by the
printer fluid to induce bubble formation. While no adverse results have yet to surface, it
is possible that more sensitive cells or proteins could be sensitive to these high
temperatures. A solenoid-based printer does not need any heating elements to induce
droplet formation. As a result, cells could experience less strain through a solenoid-based
inkjet. In addition to better cell compatibility, this characteristic could allow for a wider
variety of materials to be used with the system, especially thermo-sensitive polymers like
collagen.
Few differences exist between impulse and piezoelectric inkjets, however. Both
systems operate on the principle of a pressure gradient in the print chamber to induce
fluid flow. Piezo inkjets achieve this pressure by physically decreasing the chamber’s
dimensions in increase pressure. The solenoid valve in an impulse inkjet, on the other
hand, uses electromagnets to open its valve, and an already pressurized fluid environment
to induce flow. While the piezoelectric system has the disadvantage of slight temperature
fluctuations from resistance in the chamber walls, the solenoid system has the
disadvantage of having to constantly pressurize the fluid reservoir. Since piezoelectric
inkjets have already been shown to work with cells, this project attempted to demonstrate
that a solenoid-based inkjet could also be used to safely print cells for tissue engineering
applications.
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4.3

Is a Smaller Droplet Better?
Apart from the method of droplet formation, one characteristic that also deserved

consideration when choosing an inkjet should be the inkjet’s droplet size. This factor,
which includes the droplet’s volume among other things, can heavily affect the resolution
of the device. When considering typical uses for a printer, such as printing text or
graphics on paper, a tiny resolution is an ideal feature for accurate representation of the
element being produced. However, this feature may not be desirable for an inkjet used
for this project.
When considering how the inkjet in this project would be used, a tiny droplet size
could possibly be a disadvantageous characteristic, rather than an advantage, for the
system. For the system to be efficient as well as effective, a single drop would
theoretically be dispensed where one would want to place a cell. For this previous
statement to be effective, the drop dispensed would have to contain at least one cell.
However, the chances for a viable cell to attach could increase if more cells were
dispensed in each drop.
In an actual test of the cell printer (explained in the next chapter), a cell
concentration of 6.2E4 cells/mL was calculated from measurements. From other tests,
the printer was calculated to dispense about .290 !L per drop. Using these values and the
relationship
c = n /Vd

where c is the average cell concentration of the solution and Vd is the volume of the drop,
! calculated to be about 17.98 cells. Research performed
the average cells per drop, n , was

!
by Merrin et al. showed that a Poisson distribution could be used to adequately estimate
!
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the number cells found in a single droplet [37]. Therefore, the probability, p, of finding n
cells per drop could be estimated as

pn =

n n e"n
n!

Rounding down the value of n previously calculated, the printer theoretically had a
7.04E-5 percent probability of!having one cell per drop. Although this probability may
!
sound low, the chances for finding more than one cell per drop are significantly higher, as

shown by the blue graph in Figure 4.3.

Figure 4.3 Poisson distributions of various cell per drop averages
To put this distribution into perspective, two theoretical distributions are also
considered. If the droplet is assumed to be a perfect sphere, the actual droplet would
have a diameter of about 0.821 mm, or 0.032 in. Assuming the inkjet valve is a perfect
cylinder, that the cylinder contains the full volume of one drop, and that the cylinder has
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an inner diameter of 0.03 in., this theoretical valve would have a length of about 0.636
mm. Keeping the same length but increasing the inner diameter to 0.04 in, this would
theoretically increase the droplet volume to about 0.516 !L. Using the first relationship
defined above and using this larger droplet volume with the same cell concentration, this
larger droplet would theoretically contain about 31 cells on average. While the
probability of finding only one cell per droplet decreases to about 1.07E-10 percent, the
larger diameter would have an even better chance of dispensing multiple cells per drop,
as shown by the red curve in Figure 4.3. Now, if the valve diameter were decreased to
0.02 in, the droplet volume could drop to about .129 !L, resulting in 7 cells per drop on
average. This lower average shifts the Poisson distribution to the left, as shown by the
green curve in Figure 4.3. As a result, the probability of finding just one cell per droplet
increases to about 0.63 percent, but the overall probability of finding more than one cell
per droplet decreases.
As shown by the above examples, a larger diameter valve may actually improve
the performance of a cell-depositing system. The accuracy of the fluid deposit may not
be as precise, but to improve the likelihood for cell proliferation. However, if the system
were also to be used for fabricating a scaffold, precision would be desired. In this case, a
smaller diameter would be preferred. In such a situation, where both functions are
desired, at least two different-sized nozzles could be used, in which a larger nozzle would
be used for cells, and the smaller nozzle would be used for scaffolding material.
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5.0

DEVELOPING THE CELLULAR INKJET SYSTEM
The goal for this research project was to determine whether a commercially

available, solenoid-based inkjet system could be used as a viable cellular deposition
system. Initially, the inkjet system was intended to become the foundation for a custom
3D rapid prototyping system, similar in concept to the 3DP system developed at MIT.
One long-term goal for this project would be to add the ability to print scaffolds. If cell
viability can be confirmed, then it should also be possible to further develop this system
into a fully functional scaffold rapid prototyping device with the capability for
simultaneous seeding of cells.

5.1

Materials and Hardware
A few considerations with the materials and hardware needed to be taken into

account when the system was designed. First, the materials and hardware used in this
project needed to be biologically inert. Furthermore, because biohazardous compounds
would be used, the hardware and materials needed to be sterilizable, as well as easily
accessible and operable by an operator wearing protective gear. Lastly, the hardware
components needed to be readily available and relatively affordable; the target cost range
of parts for this system was below $5000.

5.1.1 Hardware
A Marsh Unicorn inkjet printer (VideoJet Technologies, Wood Dale, Illinois) was
used for its several inkjet heads. These inkjet heads were originally linked with a
manifold to a single input source. However, once this manifold was removed, these
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seven inkjet heads could be filled with separate fluids, which potentially allowed the
system to serve multiple functions. For example, one inkjet head could have contained a
binder solution needed to cross-link the substrate bed; a different head could have also
deposited cells into strategic locations onto the recently formed solid layer, maximizing
potential for tissue growth. With seven total inkjet valves available, the system could
have fabricated complex constructs. With respect to tissue engineering concerns, the
inkjets used in this printer should have been harmless to cells. These inkjet heads,
INKX0503450A (The Lee Co., Westbrook, Connecticut), were neither thermal nor
piezoelectric, but were instead solenoid valves. These valves provided response times as
fast as 0.25 ms and low power consumption, which lead to low operating temperatures
under normal loading conditions.

Figure 5.1 Inside the printer, showing the nozzle array and print heads
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Unlike thermal inkjets, which heated the fluid to eject it, the Lee valves required
fluid to be already pressurized in order to flow once the valve opened. To pressurize the
fluid in this system, pressurized gas was fed into the fluid reservoir. This gas was not
used to aerosolize the fluid, as in a continuous inkjet system. Instead, the gas simply
provided a pressure gradient to generate flow throughout the inkjet head. The very first
iteration of the system utilized an AC-powered compressor to provide compressed air.
This setup allowed for a somewhat mobile system. As long as an AC source was
available, the system was usable. However, very early in the testing, the compressor
seized. At this point, other options for pressurizing the system were considered. While
another compressor could have provided an easily transportable source of pressurized
gas, the cost of replacing the equipment would have been quite expensive. An
appropriate compressor would have had to output sterile air, since the gas was originally
intended to contact the fluid. This requirement would have required the use of an oil-free
compressor, which were quite expensive. Furthermore, using another compressor would
have again presented the risk of mechanical breakdown.
Because of the potential issues with using compressors, the decision was made to
switch to compressed gas canisters. Compared to most compressors, compressed gas
cylinders were not as portable. Furthermore, because the gases were compressed to a
high pressure, great care needed to be taken when handling cylinders. However, gas
cylinders offered the highest reliability, since no mechanical parts were needed (apart
from a regulator). The reduced portability was also a non-issue, since this system was
not going to travel outside a clean environment. Furthermore, because there was no
mechanics involved, the gas supply possibly contained less aerosolized oil than gas from
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a compressor. The cost of a cylinder, depending on the gas used, was usually more
affordable when compared to a compressor. For example, at AirGas West, a local gas
supplier, 100 cu-ft of compressed air costed $5.35. Assuming an airtight seal, this
cylinder could have potentially lasted for months.
Initial testing of the gas-cylinder-powered setup utilized compressed CO2 to
pressurize the system. While this worked fine to dispense Milli-Q water to ensure basic
functionality, CO2 would have been an improper gas to use if cells were going to be used.
CO2 could have made the media more acidic, killing the cells; furthermore, this gas could
have reduced the percentage of oxygen available to the cells. Therefore, compressed air
(AirGas West, San Luis Obispo, California) was substituted for the CO2 tank. According
to official drawings from The Lee Co., the solenoid valves had a maximum operating
pressure of 10 psi. The compressed air cylinder was pressurized to around 20,000 psi.
Therefore, a regulator was added to reduce the output pressure to 10 psi.
In the modified design, the system allowed the compressed air to directly contact
the loaded fluid. While this reduced mechanical complications that could occur with
moving parts, another problem associated with this fix needed to be resolved. If the gas
supply were contaminated, the cells would become at risk for contamination. To address
this concern, PharmAssure vent filters (Pall Medical, East Hills, New York) were added
in between the gas supply and fluid reservoir. This filter was chosen for a couple of
reasons. First, the filter’s inlet and outlet connectors utlized luer-lock connectors. This
connector allowed for easy assembly when working in the sterile hood. The more
important reason for using this filter was its 0.2-!m hydrophobic membrane, which was
commonly used in pharmaceutical companies for filtration purposes.
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Figure 5.2 A sample vent filter is attached to top of syringe screwcap

It is worth noting that, while a 0.2-!m pore size was treated as an industry
standard, the FDA did not formally designate a standard pore size for filters. Rather, the
administration defined a challenge using the organism Brevundimonas (Pseudomonas)
diminuta. To qualify as a sterilizing filter, the filter had to retain at least 107 organisms
per cm2 of filter area [60]. Therefore, by using 0.2-!m filters, which passed the
challenge, most microorganisms that might be present in the gas supply would have been
prevented from contaminating the cells.
Additional hardware was required to be able to control the custom hardware via a
computer. To provide a modular and scalable hardware environment, equipment from
National Instruments was chosen. A NI PXI-7334 motion controller (National
Instruments, Austin, Texas) in a 6-slot PXI chassis (National Instruments), connected to a
computer via a PXI-to-PCI card (National Instruments), provided the computer to
hardware interface. The I/O ports of the motion controller output a 5V TTL signal.
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Initially, a simple 5VDC relay was used to switch open the valves. The TTL signal from
the motion controller was used as the relay’s switching signal, while a DC Regulated
Power Supply (Extech Instruments, Waltham, Massachusetts) provided 12VDC of power
output for the solenoid valve. This setup, however, proved to be dangerous to the valves.
While no apparent damage was seen, the external body of the valve became very hot.
Upon consulting with a Lee Co engineer, it was determined that the valve was being
overdriven.
Therefore, to trigger the valve but not risk damaging the hardware, an
IECX0501350AA spike-and-hold circuit (The Lee Co) replaced the relay circuit. Like
the relay, this pre-built circuit provided the solenoid valve with a 12VDC pulse to open
the valve, but then kept the valve open using a lower hold voltage so as to not overdrive
it. Upon substitution with the spike-and-hold circuit, a difference in operating
temperature was immediately noticed; the exterior wall of the valve was no longer
burning to the touch. To quantify the operating temperature, a thermocouple, attached to
a multimeter, contacted the exterior wall of the valve and temperatures were recorded
every minute as the valve repeatedly dispensed with a 32ms pulse train. With this circuit,
external body temperatures did not exceed beyond 23ºC, even with repeated, long periods
of holding the circuit open. While this temperature was too cold for ideal cell living
conditions, it was not too hot to denature proteins.
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Figure 5.3 Spike and hold circuit with power and inkjet wires connected

Figure 5.4 Chart plotting detected solenoid temperatures during repetitive dispensing

Building upon the original goal of developing a rapid prototyping system with the
inkjet, some motion hardware was modified to be used with National Instruments
equipment. Two stepper motors, Zeta 57-51 (Compumotor, Rohnert Park, California),
and beds provided a two-dimensional platform. In order to control this 2D bed, the
motors were wired to a MID-7602 stepper power drive (National Instruments) to provide
power to the motors. The purpose of this hardware was to allow for automated,
positioned fluid deposition. The 2D bed would have provided XY positioning for
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fabrication of the current layer. A third motor would have provided Z-axis motion to
raise or lower the build platform. While the 2D bed was wired for use with the motion
controller and was already functional, the cell viability tests did not utilize any motion to
minimize potential sources for contamination. Future projects, however, could utilize the
hardware to experiment with cell patterning.
Based off the expenses for this project, the cell depositor was relatively cheap
compared to a commercial rapid prototyping system. The suggested retail price for the
least expensive ZCorp 3D Printer was about $19,000. In contrast, most of the
components used in this project could have been obtained for under $10,000 total (see
Appendix G). With institutional discounts, however, the cost to purchase the majority of
the hardware was reduced to the $6000 range. The most expensive components, by far,
were from National Instruments. However, this sub- $6000 cost even included the cost of
the stepper power drive, which was not used. Although the inkjet valves were provided
at no cost, the hardware expense calculation included the cost of seven valves and spikeand-hold circuits.

5.1.2 Materials
Nalgene 180 PVC tubing (Thermo Fischer Scientific, Rochester, New York),
which resisted many chemicals and was biocompatible, was chosen to link the
compressed air supply to the syringe inlet. This tubing was also used to create a luer-lock
interface at the outlet of the syringe. To make everything easy to assemble, as well as
allow for use of the sterilizing filters, luer-lock adapters (Value Plastics Inc., Fort Collins,
Colorado) were fitted onto the tubing ends. A 50 mL polypropylene screw-cap reservoir
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(AutoMate Scientific, Berkeley, California) served as the inkjet fluid reservoir. Because
the reservoir and its assembly parts also came in contact with cells, they needed to be
autoclavable in order to be safely placed in the laminar flow hood. The rest of the tubing,
while also autoclavable, did not need to be autoclaved, as it would have been exposed to
the environment after assembly and was sterilized in some fashion. For example, the
tubing between the gas supply and reservoir had a vent filter at the reservoir end to
sterilize the air that contacts the cells.
On the other end, the tubing that went from the reservoir to the inkjet inlet was
sterilized using a 2.5% diluted glutaraldehyde solution (Sigma-Aldrich, St. Louis,
Missouri) prior to use. Glutaraldehyde was chosen for a couple of reasons. First, it was

Figure 5.5 Nalgene tubing with pinch clamp and luer-locks on syringe tip

readily available in the lab where the inkjet system resided. Second, glutaraldehyde was
non-corrosive to a variety of materials, including rubber and plastics used in this project.
On the other hand, glutaraldehyde presented some minor health risks to humans. Short58

term exposure to this chemical was shown to cause some respiratory and skin irritation;
long-term exposure, however, could have lead to skin sensitization or asthma [58].
Furthermore, glutaraldehyde was also toxic to water organisms. Therefore, this chemical
needed to be handled in the laminar flow hood with protective gear to minimize any
exposure and had to be carefully disposed of to not harm the environment.
A simple cabinet was built to minimize exposure of the inkjet head to the
environment. The design was comprised of a five-sided enclosure with a stretchable
material covering the last side. The inkjet head was integrated with the stretchable
material. This design characteristic would allow the cabinet to move while keeping the
inkjet head in a stationary position above the cabinet’s floor. With this style, the cabinet
would have to be mounted atop a 2D stage to allow computer-controlled positioning to
take place. 0.220-inch-thick acrylic was used to construct the five walls. Plexiglas, an
inert material, would allow for easy viewing as the system is in operation. Furthermore,
it is much more robust than glass. However, this material could graze with prolonged
exposure to solvents. Since alcohol would be used in the protocol to wipe down the
cabinet, future revisions should use glass or a solvent-resistant plastic. For the
stretchable cover, latex sheets (Small Parts Inc, Miramar, Florida) were used. This
material was chosen for its low cost. However, like acrylic, it is sensitive to solvents like
alcohol. Buna-N, also known as nitrile, would be a more appropriate material, as it is
solvent resistant. An attempt was made to use this material, but the chosen sheet was too
thick to be elastic.
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5.1.3 Software
From the project’s conception, LabView (National Instruments) was chosen as the
software development platform for the system. The integration between NI’s hardware
and LabView, as well as the user-friendly graphical programming interface, made
LabView an easy choice. In order to control the digital I/O of the motion controller (as
well as the 2D bed), the NI-Motion library was installed with LabView.
A simple virtual instrument (VI), called Cleaning.vi, was created to control
sterilization of the internal inkjet components that cannot be autoclaved. The VI was
designed to run over a ten-hour duration, in which glutaraldehyde was slowly dispensed
through the printer. Every 30 seconds, a quick 15 ms voltage spike caused the solenoid
to dispense a drop of glutaraldehyde. In addition, every five minutes, ten 15ms pulses,
which were intended to help dislodge any dead cells or organisms, took place. This
pattern of increasing volume continued over the course of a half-hour; every ten minutes,
50 10ms pulses took place, and every 20 minutes, 100 15 ms spikes took place.

Figure 5.6 Cleaning.vi with 10-minute case shown at bottom
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Finally, after every half-hour, a full, one-second spike replaced the contact area
with fresh glutaraldehyde. After ten hours, the VI automatically paused its execution.
Following the sterilization, it was necessary to purge the system of any remaining
glutaraldehyde, as it harmed any cells it came in contact with. Therefore, the operator
had to manually activate a glutaraldehyde purge function of the VI, which repeatedly
dispensed the remaining fluid until stopped by the operator. After the glutaraldehyde
purge, an optional media purge was available. This function was added to ensure that no
glutaraldehyde remained in the system. If activated, this function flushed the system with
media that was loaded by the user following the glutaraldehyde purge.

Figure 5.7 Cell printer test VI with default values set
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Figure 5.8 Block diagram of the cell printer test VI

A separate VI was created for running cell viability tests. While relatively simple,
this VI provided some control over the depositing process. A control was added to
change the open-valve duration. Furthermore, an additional control was added to specify
the duration of the closed-valve state. By default, the open and closed states had the
same 10ms duration. The ability to specify how many times to dispense fluid was also
included; by default, the VI only dispensed fluid once. If this value was greater than ’1’,
then the VI waited to dispense the next drop using the closed-valve duration.

5.2

Testing for Viability
Before any future work can be carried on with the system’s development, the

system needed to be shown to safely print cells. As a result, cell viability needed to be
assessed in this project. While not intended to provide a thorough test of the system, this
initial viability test had to demonstrate that at least one living cell could be safely
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dispensed by the system with the designed protocols. If successful, this test would have
provided proof-of-concept evidence in support of the solenoid-based inkjets.

5.2.1 Cell-specific Resources and Caveats
For this specific viability test, NIH 3T3-L1 mouse fibroblasts were used in the
system. This cell type was fairly robust and reached confluence in a short amount of
time. Additionally, the materials needed to sustain the cell type were relatively common.
For example, a complete medium needed for this cell type could have consisted, at a
minimum, of 10% fetal bovine serum (Sigma-Aldrich) in Dubeco’s Modified Eagles
Medium. To minimize the risk of contamination in the medium, 1% of
penicillin/streptomycin and Fungizone was added to the medium. While the quick
growth rate of this cell type was advantageous, confluence needed to be carefully
monitored. If the cells were to reach complete confluence, they would have begun to
differentiate into adipocytes. Therefore, the cells were usually passaged at a rate of 1:10
to increase the time to reach confluence.

5.2.2 Maximizing Sterility
Although this system was far from usable, sterility was an issue that needed to be
addressed. The ultimate goal for this system was to create a fully-seeded scaffold. If this
system was ever to be used to actually create implantable tissues, then it had to meet
FDA requirements for sterility. These requirements were put in place to maximize
patient safety when receiving implants. Therefore, an attempt was made to build sterility
into the system.
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A number of researchers used various techniques to clean their inkjet systems. In
a study by Pardo et al., inkjet cartridges were thoroughly rinsed in deionized water up to
100 times, then alternatively rinsed in ethanol and water [44] before being loaded with
the “ink.” With this technique, the group was able to successfully print self-assembling
monolayers onto gold substrates. This technique was also adopted by Roth et al. to print
smooth muscle cells onto a coated, glass coverslip [47]. Boland et al. used a similar
technique with the inkjet cartridges they used, except they only rinsed the cartridge
several times [7]. However, in addition to rinsing the cartridge, the group placed their
entire printer assembly and cartridge in a laminar flow hood and UV irradiated overnight.
With this technique, Boland et al. were able to successfully print a scaffold and
simultaneously dispense cells onto the scaffold.
A number of steps needed to be taken to ensure the system would be as sterile as
possible. First, any components outside the inkjet enclosure that came in direct contact
with the cells without passing through a filter needed to be fully sterilized. Therefore, the
syringe reservoir, adapters, and tubing linking the reservoir to the inkjet inlet were
autoclaved; these parts remained sealed in its sterile pouch until the cells were ready to be
loaded. Once the cells were ready, the reservoir was assembled inside the laminar flow
hood, following aseptic procedure. The reservoir remained in the laminar flow hood until
the bottom port was pinched shut, the solution loaded, and the reservoir capped and
topped with the vent filter. By following this procedure, contamination to the internal
portion of the reservoir was kept to a minimum as the fully assembled reservoir was
removed from the laminar flow hood.
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Figure 5.9 An assembled reservoir in laminar flow hood, filled with 2.5% glutaraldehyde

A protocol, sufficient enough to maximize sterility for this half of the system, was
more challenging to create. The main problem was with the printer heads. These valves
could not be simply autoclaved, as it had electronic components and other wetted
materials that were not suitable in high temperatures. Placing the entire system in a flow
hood was considered; its sheer size, however, made this an unlikely option. Furthermore,
should the 2D stage be integrated with the system, concerns with contaminants from the
stages’ lubrication made the entire system unfeasible for the shared hood. Therefore, the
issue of maximizing sterility with the inkjet system was tackled by separating the
environment from the internal system.
The strategy to maximize sterility of the internal system involved purging the
fluid path with a fluid. In this strategy, any components after the reservoir that came in
contact with the cell solution was cleaned using a known sterilant. For this experiment, a
diluted glutaraldehyde solution was the sterilant of choice. As mentioned earlier, the
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cleaning VI was programmed to dispense this sterilant over the course of ten hours. This
duration was chosen because it was the average contact time for similar glutaraldehyde
solutions cleared for use as sterilants by the FDA [59]. Ideally, this solution would
suffice if the internal components remained completely isolated. However, the system
could become at risk upon changing of the fluid reservoirs, as the internal tubing would
become exposed upon disengagement of the luer locks. An additional filter was
considered but not used because the opening of the filter would have also been exposed
upon disengagement. Therefore, to minimize this risk, any reservoir-swapping procedure
in the protocols was quickly performed to limit the time the tubing was exposed. An
alternate solution could have been to connect the tubing in the laminar flow hood, though
this method would have required extra precautions to ensure the tubing was sterile.
Furthermore, since the connecting components had to be external to the flow hood, the
risk of contamination at the connection point still remained. As a result, this alternative
was not implemented.

5.2.3 Testing Methodology
The goal for this thesis was to develop an inkjet system that can successfully
dispense living cells onto a substrate. While other commercial inkjet technologies and
systems have been successfully used in previous research projects, the inkjet system
utilized in this project was untested for use in tissue engineering applications. Therefore,
the inkjet heads and protocols developed for this custom system needed to be tested to
evaluate its potential. The highest priority for any cell-capable printing system was to
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demonstrate cell viability during and immediately after printing [40]. Therefore, before
any work can continue to further develop this system, cell viability had to be ascertained.
In order to obtain cells for testing, a trial run with cells was performed with the
inkjet system. A day before the trial, three disassembled reservoirs were autoclaved
according to protocol (see Appendix B). One reservoir was filled and loaded with 2.5%
glutaraldehyde (see Appendices B & C) while the printing chamber was cleaned, then the
cleaning VI was allowed to run overnight (see Appendix F). After purging the remaining
glutaraldehyde, the second reservoir was filled with sterile media, loaded into, and
purged through the system to ensure all traces of glutaraldehyde were removed. Finally,
the third reservoir was prepared for use. At this time, the cells were removed from the
incubator and re-suspended with fresh media in the cell laminar flow hood. The cells
were then moved to the shared hood and transferred into the reservoir and control
container, explained below. This reservoir was then carefully loaded into the system and
printed into a sterile culture plate for assessment.
A simple control was also created to compare the inkjet results with. Before the
reservoir was loaded with fluid, the fresh cell suspension was divided into two even
batches. These batches were randomly assigned to one of two groups. One group was
loaded into the reservoir and printed. The batch assigned to the other group remained in
the laminar flow hood and was not printed. Theoretically, the only difference between
both groups should have been that one group underwent the inkjet process. In reality, the
printed cells also were briefly exposed to a non-aseptic environment; however, because
only the immediate cell viability was being evaluated, this factor was considered
negligible.
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Figure 5.10 Inkjet system during purging with 2.5% glutaraldehyde

To evaluate cell viability, a trypan blue exclusion assay was performed on the
cells (see Appendix E). To perform this assay, a cell suspension was created by first
trypsinizing then centrifuging cells into a pellet, then re-suspending in phosphate buffer
solution (Sigma-Aldrich). This suspension was then mixed with 0.4% trypan blue
(Sigma-Aldrich), and about 10 !L of the mixture was placed into a hemocytometer
(INCYTO, South Korea). Normally, cells are colorless in appearance. Trypan blue,
which is a staining dye, cannot penetrate the outer membrane of cells; because of this
fact, viable cells will continue to appear colorless when exposed to trypan blue. Nonviable cells, however, will stain blue, as the dye is able to penetrate the membrane and
stain the cytoplasm. Under the hemocytometer, both viable and non-viable cells can then
be counted to determine the percent viability.
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The trypan blue exclusion assay was performed twice to evaluate the effect of the
printing process on the two blocks. First, immediately after assigning the two batches to
their group, a 50-!L sample of cell solution from each batch was taken. The sample from
each batch went through the trypan blue assay to obtain a cell viability count, which
served as a baseline measurement. Another assay was performed on both groups
immediately after the print group underwent the printing process.

5.3

Issues Encountered
Initial test-runs of the system revealed a number of technical issues, which was

expected from an untested design. The first issues encountered were related to the
cleaning process. In the first trial of the cleaning process, the glutaraldehyde was loaded
properly into the system and set to dispense overnight using the cleaning VI; after the 10hour process completed, however, it was observed that only 5-7 mL of the 50 mL
actually dispensed. Inspection of the system revealed that at some point during the
process, all available air pressure was lost. The cause for the pressure loss was believed
to be a minimally opened gas cylinder that was supplying gas too slowly. Despite this
irregularity, the internals of the inkjet system did still receive the 10-hour contact time.
This issue was resolved by simply opening the valve more to provide enough airflow to
counter any leaks. Once pressure was restored to the system, the glutaraldehyde was
purged, and media was flushed through the system following the protocol.
Ironically, once the low dispensing problem was resolved, a subsequent test of the
cleaning VI with a full 50 mL of glutaraldehyde then resulted in a completely empty
reservoir after the ten-hour runtime. Evaluation of the code revealed that the one-second
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drop intervals alone resulted in 150 mL of fluid being dispensed, based on a measured
flow rate of .290 !L/ms from the nozzle. Therefore, in order to have a surplus of
glutaraldehyde remaining to ensure a complete ten-hour contact-time, the cleaning VI
was modified, removing the one-second interval, which left the 30-second interval as the
shortest interval. This revised cleaning algorithm should have resulted in a fluid surplus
between 20-30 mL if the syringe was filled to 50 mL. A subsequent run after making the
change resulted in a 25 mL surplus, which suggested the algorithm’s performance was
now correct.
An issue with the trypan blue test required changes to the protocol. A cell
suspension, this time known to be near confluent, was printed through the system. The
original recipe for the trypan blue exclusion test called for 1mL of PBS to re-suspend a
centrifuged cell pellet from 1mL of suspension, and 10 !L of trypan blue. An alternative
recipe, which consisted of 200 !L of cell suspension, 300 !L of PBS, and 500 !L of
trypan blue, was also tested. However, upon examining the samples from either recipe in
a hemocytometer, a “grainy” pattern was observed. Rather than seeing cells either
transparent or filled with blue, the entire hemocytometer showed what seemed to be
grains of trypan blue. It was not clear which cells were viable and non-viable. Reexamining all the supplies used, the root cause of the problem was found to be the media
used. The DMEM used in the trial already contained FBS. Research about trypan blue
indicated that the staining molecule attaches to serum proteins. Therefore, instead of
entering non-viable cells, the trypan blue was instead binding with proteins in the
FBS/DMEM culture medium, resulting in the grainy blue slide. It was also believed that
the PBS used was of a 10X concentration, which could have caused osmotic lysis. To
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resolve this issue, a simpler trypan blue recipe was used, which consisted of 50 !L of
resuspended cells and 50 !L of trypan blue. To re-suspend the centrifuged cells this
time, serum-free DMEM-F12 media was used. These changes resulted in usable
hemocytometer slides.

Figure 5.11 Light microscope showing viable cells in a printed solution

A problem that involved some of the luer-lock surfaced repeatedly during the
printing process. Following any printing or purging, the connection between the syringe
and inlet tubing of the inkjet head often became stuck. Efforts to loosen the luer-locks by
hand often failed, sometimes requiring pliers to apply extra torque. It was first believed
that the glutaraldehyde was possibly bonding the two luer-locks together. Glutaraldehyde
was known to be non-corrosive to metals, rubbers, and plastics, but was also known to
leave behind a sticky residue. To test this sticky hypothesis, a tightened luer lock was
submerged in 2.5% glutaraldehyde overnight. The following morning, attempts to loosen
the lock by hand failed. To work around this issue, the luer-locks were no longer secured
tightly; instead, the locks were screwed until they barely formed a seal. Although this

71

workaround may have temporarily worked, this issue might also have shared similar
causes with the final issue, described below.
The most limiting issue experienced thus far was the printer nozzle becoming
clogged. After a number of prints with the system, the nozzle became clogged. The
source of the clog was located at the exit nozzle of the printer assembly. An attempt to
unclog the nozzle by increasing air pressure failed after the syringe outlet tubing burst
free from the syringe. This result raised the issue of tubing security, especially since
electronic components were being used around the system. To continue operation of the
system, a temporary workaround, which consisted of rerouting the solenoid outlet tubing
to an unused, unclogged nozzle, was enacted. While this temporarily resolved the issue,
the cause was not known at the time of occurrence. It was later realized that the media
purge process was most likely the reason for the clog. The culture media contained
nutrients important in cell reproduction. Part of this milieu consisted of amino acids,
which were vital for protein synthesis. Since glutaraldehyde is a fixative, any leftover
sterilant would have polymerized these amino acids upon contact, which would have
formed into a gelatinous solid. As subsequent sterilizations occurred, more of the solid
probably formed and aggregated until the printer nozzle eventually clogged. Therefore,
in order to resolve this issue, the protocol would have to be modified to utilize an inert
fluid, like saline, rather than culture media. Furthermore, this saline flush should be
performed over a long time period, as glutaraldehyde was known to persist through
flushes longer than originally expected.
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5.4

Results
The initial test with cells only tested for signs of cell viability. The printing

procedure was performed as outlined in section 5.2.3. For each block, a single sample of
cell solution was taken. As shown in Figure 5.12, a 96.8% cell viability was observed
from the single sample taken after printing.

Figure 5.12 Calculated data from print vs. control group

5.5

Discussion of Results
The print results gave somewhat promising data. This data showed that some

printed cells could survive the printing process. Due to the low sample size and single
tests performed on each block, however, not much inference can be made between the
blocks or other research. However, since the purpose of this project was just to provide a
proof-of-concept for a possible cell printer design, detailed experimental data was not
important. It is possible, however, that subsequent studies, if conducted, could provide
this statistical comparison with the other cell printing research already published. With
the promising result shown above, performing this subsequent work on the system to
determine its true potential would definitely be justified.
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6.0

FUTURE WORK AND CONSIDERATIONS
This project aimed to introduce a system capable of rapid prototyping a scaffold,

as well as simultaneously seeding cells. In order to make this task possible, a commercial
inkjet system was gutted, integrated with LabView hardware, and modified to allow
multiple materials to be used. In addition, the framework for 2D motion with stages was
laid out. Once functional in LabView, the system was further modified to facilitate for
the safe integration of cells.
While the limits of the system are currently being determined in a separate
project, initial tests using the system do show potential for the system. The initial results
support a need for further study to determine the full potential of the system in its current
version. The numerous problems experienced along the way, however, also demonstrate
that more work is needed to optimize the system.

6.1

What Needs to Be Done
Although it has been demonstrated that cells can survive the printing process

through the developed system, more work needs to be performed to improve the system.
For example, while immediate survival of cells has been demonstrated, a limit needs to
be determined for the cells during the printing process. The RP process can be a slow
and tedious process, often taking hours to complete a model. In its current state, the cell
printer is unable to support living cells for more than 20 minutes. Therefore, the system
needs to be modified to provide “life support” while the cells wait both in the system and
on the printed substrate. This life support system would most likely require a humid,
temperature-controlled and print environment. Furthermore, a way to maintain a 5% CO2
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atmosphere within this environment might be necessary to fully simulate incubator
conditions.
Continuing on the topic of limits, the operating limits of the system also need to
be determined. While some limits, such as maximum operating pressure, are already
known, the clogged valve experienced during testing demonstrated that the system does
have a limited capacity for cell population. A maximum density needs to be determined
to ensure that the system will not become clogged again. Protocol changes may also need
to be implemented. For example, another purge cycle follow cell printing should be
considered to ensure that any remaining cells get removed.
Second, the resolution of the system needs to be drastically improved. Currently,
the system is only capable of printing dots in the millimeter range. Articles discussed in
this paper mention resolutions in the micron scale. In order to have any relevance in cell
depositing, this system needs a significant increase in resolution. Because the inkjet
valves used in this project were taken from a system intended to print large text on boxes,
it is possible that the hardware is not capable of reaching a minute resolution. Therefore,
hardware changes might be necessary to improve the resolution. While smaller volume
solenoid valves are available from The Lee Co., using piezoelectric inkjet heads is not of
the question.
Third, for the system to have any relevance in creating 3D models, two things
need to be accomplished. First, some existing hardware would need to be replaced in the
system. For example, the motion controllers used in this project are only capable of 2D
movement. Therefore, if a third stepper stage were to be added for Z-axis motion, the
motion controller would need to be replaced. Position sensing would be another ideal
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addition into the system. There is currently no real feedback system to determine where
the stage is in its vector space. The system does have home sensors and forward/reverse
sensors to know when it reaches the home position and maximum travel allowable. The
system “guesses” its position by how many steps the motors have turned. While this
method would be adequate for generic inkjet applications, a more accurate positioning
system would be required if the system will be used to dispense cells on the micron scale.
One method to gain accurate positioning could be to add encoders to the stage setup.
Encoders have a sensor that read a calibrated scale, and convert that reading into a
position. By adding three encoders to each stage and providing the feedback via the
stepper motor drivers into the VIs, accurate position would be possible if paired with a
smaller-diameter nozzle. It should be worth noting that once these hardware changes
take place, the LabView VIs already created would have to be modified to handle the
extra dimension and positional feedback.
In addition to adding better position detection, the overall design needs to be
modified to allow movement of the inkjet head rather than the build platform. The need
for this design change becomes apparent if the system were to be modeled after a 3D
bioplotter. The liquid bed would easily become unstable if it were mounted to a 2D
stage. Therefore, in order for the system to successfully transform into a 3D rapid
prototyping system, an overhead 2D-motion stage that can accommodate the inkjet head
needs to be built. The Z-axis movement, however, can still raise or lower the build
platform. Because of these changes, the chamber design will also need to be modified in
order to enclose the overhead stage.
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Finally, although other inkjet systems have dispensed scaffolding material, this
system has not been tested with such materials. The solenoid valves could theoretically
be adapted for either a 3D Printing or 3D plotting setup. Lam et al. have already shown
that a 3DP-based system could fabricate biocompatible scaffolds. Furthermore, Pfister et
al. have demonstrated that 3D plotters can also be used to fabricate biocompatible
scaffolds. To fully utilize its potential, the system’s compatibility with scaffolding
materials needs to be established. If the system can dispense scaffolding material, such
as PCL, then it should be possible to create a fully bioactive scaffold from scratch.

6.2

Conclusion
With demand for organs outpacing the available supply, tissue engineering has

attempted to ease this deficit. The limitations of traditional tissue engineering, however,
have pushed researchers to investigate other methods of tissue fabrication. This research
project has focused on one such tangent of tissue engineering research: tissue rapid
prototyping. Various RP technologies investigated by previous studies indicate that most
of these technologies could be used in some form of TE research.
This research project aimed to establish the foundation for a tissue rapid
prototyping system based on a relatively unused subset of inkjet technology. The
findings from this demonstrate that printed cells can survive through the designed cellprinter system. Although the long-term survival rates have yet to be determined with this
setup, the initial positive results indicate that further research with the system should take
place. With multiple inkjet heads available and flexibility in the software and hardware
environment, it should be possible to refine the system into a tool that can fabricate pre-
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seeded tissue engineering constructs, which should be better able to develop into tissues
when compared to tissues created using traditional methods.
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APPENDIX A - GLUTARALDEHYDE PREPARATION PROTOCOL
A.1

Materials & Equipment

-

25% Glutaraldehyde (Sigma-Aldrich)

-

Milli-Q water

-

250 mL media bottle

-

Plunger syringe w/ luer-lock tip

-

0.2-!m syringe filter

-

Sterile serological pipettes

-

Laminar flow hood

A.2

Safety

-

Perform procedure in laminar flow hood.

-

Do not ingest or allow glutaraldehyde to come in contact with skin!

-

Discard used pipettes and pipette tips in biohazard bin or used pipette tip
container.

-

Wear eye protection gloves, closed-toe shoes and pants during entire procedure.

A.3

Set-Up

A.3.1

If media bottle is not sterile, autoclave media bottle and cap.

A.3.2

Spray down work surface of laminar flow hood with IPA or ethanol and
wipe with Kimwipe.

A.3.3

Spray outer surfaces of all containers and packages, then place in laminar
flow hood.
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A.4

Procedure

A.4.1

Use plastic plunger syringe to take up non-sterile Milli-Q water.

A.4.2

Attach syringe filter to syringe tip, and dispense Milli-Q water into sterile
media bottle. Remove syringe tip.

A.4.3

Repeat steps A.4.1 and A.4.2 until 90 mL of sterile water is dispensed.
Discard syringe and filter.

A.4.4

Using an unused 10mL serological pipette, add 10 mL of 25%
glutaraldehyde solution to media bottle. Discard pipette.
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APPENDIX B - INKJET RESERVOIR ASSEMBLY PROTOCOL
B.1

Materials & Equipment

-

Bottle or vessel containing printer fluid

-

0.2 micron vent filter (Pall Medical)

-

50cc syringe with cap (Automate Scientific)

-

3” length of 1/8” ID PVC tubing (Nalgene)

-

Tubing pinch-clamp

-

Female luer-lock to 1/8” tubing barb adapter

-

Female-luer-lock cap

-

Self-sealing sterilization pouches

-

Sterile serological pipettes

-

Autoclave

-

Laminar flow hood

B.2

Safety

-

Ensure all caps are tightly screwed to ensure no leakage from syringe.

-

Wear eye protection gloves, closed-toe shoes and pants when using hazardous
chemicals.

B.3

Set-Up

B.3.1

Ensure that all components of assembly are disassembled.

B.3.2

Place tubing, luer-lock components, and pinch clamp in small sterilizing
pouch and seal.
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B.3.3

Place syringe and cap (unscrewed from syringe) in large sterilizing pouch
and seal.

B.3.4

Place pouches into autoclave and use “pouch” setting if available,
otherwise autoclave for 20 minutes.

B.3.5

Spray down vessel containing printer fluid and autoclaved pouches, and
place in flow hood.

B.3.6

Wear nitrile gloves and spray down with IPA or ethanol.

B.4

Procedure

B.4.1

Open pouches, remove tubing and pinch-clamp, insert tubing through
openings of pinch-clamp, and pinch tubing shut.

B.4.2

Remove female luer-lock barb adapter from small pouch and insert onto
either end of tubing.

B.4.3

Remove one male-threaded luer-lock cap from small pouch and tighten
onto luer-lock.

B.4.4

Remove syringe from large pouch, and insert other end of tubing onto
bottom nozzle of syringe.

B.4.5

Using a sterile serological pipette, add printer fluid into syringe.

B.4.6

Remove cap from large pouch, and screw cap tightly on syringe.

B.4.7

Remove vent filter from packaging and screw tightly onto syringe cap.

B.4.8

Remove one male-threaded luer-lock cap from small pouch and screw
onto other end of vent filter.
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APPENDIX C - INKJET LOADING PROTOCOL
C.1

Materials & Equipment

-

Completed syringe reservoir from Appendix B

-

Compressed air cylinder (AirGas West)

-

Regulator w/ 1/8” ID tubing barb adapter

-

8000-0020, 1/8” ID tubing (Nalgene)

-

MTLL230-1, male luer-lock to 1/8” ID barb adapter (Value Plastics)

-

P-850X, Male luer-lock to 1/16” ID barb adapter (Upchurch Scientific)

-

CFT-01-10, 1/16” ID tubing (Small Parts Inc)

-

STCR 16/18, syringe tubing reducer (Small Parts Inc)

-

TGY-050-10, 0.050” ID tygon tubing (Small Parts Inc)

C.2

Safety

-

Ensure all caps and adapters are tightly screwed to ensure no leakage occurs.

-

Wear eye protection gloves, closed-toe shoes and pants when using hazardous
chemicals.

-

Ensure regulator and cylinder are shut off and tubing pinched shut when
disconnecting any tubing.

-

Place gas cylinder between yourself and regulator when opening gas supply.

-

Do not use equipment if gas connections are leaking.
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C.3

Set-Up

C.3.1

Attach one end of tygon tubing to inlet port of inkjet valve, and attach
smaller diameter nozzle of syringe reducer to other end of tubing.

C.3.2

Attach one end of 1/16” ID tubing to larger nozzle of syringe reducer.

C.3.3

Insert barb of P-850X adapter into other end of 1/16” ID tubing.

C.3.4

Tighten FTLLP-1 cap on P-850X adapter.

C.3.5

Attach regulator to cylinder valve, following manufacturer’s instructions.

C.3.6

Attach one end of 1/8” ID tubing to barb on regulator.

C.3.7

Attach barb of MTLL230-1 to other end of 1/8” ID tubing.

C.4

Procedure

C.4.1

Transfer completed reservoir assembly to ink-jet workbench and hold
vertical using test tube clamp and stand.

C.4.2

QUICKLY remove luer-lock caps from both tubing-side of reservoir
assembly and from P-850X adapter, then attach luer-locks. DO NOT
OVERTIGHTEN LUER-LOCKS!

C.4.3

Remove luer-lock caps from both vent filter and from gas-supply tubing,
then attach gas-supply tubing to vent filter.

C.4.4

Disengage pinch clamps on reservoir assembly tubing and gas-supply
tubing.

C.4.5

Ensure regulator screw is loose by rotating screw counterclockwise.

C.4.6

Slowly turn cylinder screw counterclockwise to open cylinder valve, and
allow regulator pressure to stabilize. Check for leaks.

C.4.7

Slowly turn regulator screw clockwise until low-pressure gauge reads 10
PSI.

C.4.8

Power on DC regulated power supply.
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APPENDIX D - INKJET UNLOADING PROTOCOL
D.1

Materials & Equipment

-

Loaded inkjet system from Appendix C

-

Compressed air cylinder (AirGas West)

-

Regulator w/ 1/8” ID tubing barb adapter

-

382213, Dual DC power supply (Extech)

-

FTLLP-1, female luer-lock cap

D.2

Safety

-

Ensure all caps are tightly screwed to ensure no leakage occurs.

-

Wear eye protection gloves, closed-toe shoes and pants when using hazardous
chemicals.

-

Ensure regulator and cylinder are shut off and tubing pinched shut before
disconnecting any tubing.

D.3

Set-Up

D.3.1

Use the purge feature in the current LabView VI to remove any remaining
fluid stored in the reservoir.

D.3.2

Power down the dual power supply before disconnecting any tubing.

D.4

Procedure

D.4.1

Turn cylinder screw clockwise to shut off cylinder gas supply.

D.4.2

Turn regulator screw counterclockwise until diaphragm is disengaged.
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D.4.3

Shut off DC regulated power supply.

D.4.4

Loosen luer-lock between gas tubing and vent filter to bleed off excess air
in low-pressure side of regulator.

D.4.5

Slowly turn regulator screw clockwise until air barely starts to flow
through tubing. Vent remaining air until high-pressure gauge reads 0 PSI.

D.4.6

Use pinch-clamps to clamp gas tubing and syringe outlet tubing shut.

D.4.7

Tighten luer-lock cap onto gas tubing adapter.

D.4.8

QUICKLY disconnect ink-jet inlet tubing from reservoir outlet tubing and
tighten luer-lock cover onto inkjet inlet tubing adapter.
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APPENDIX E - TRYPAN BLUE ASSAY PROTOCOL
E.1

Materials & Equipment

-

Cell solution

-

0.4% Trypan Blue solution (Sigma-Aldrich)

-

Serum-free DMEM/Ham’s F12 culture medium (Sigma-Aldrich)

-

50 mL centrifuge tube

-

1 mL centrifuge tube

-

Sterile pipette tips

-

10-1000 !L micropipettes

-

Handheld tally counters

-

DHC-N01, C-Chip disposable hemocytometer (INCYTO)

-

Inverted microscope (Olympus)

E.2

Safety and Notes

-

Perform procedure in laminar flow hood.

-

Do not allow Trypan Blue or cell solution come in contact with skin.

-

Wear eye protection gloves, closed-toe shoes and pants when using hazardous
chemicals.

-

Discard pipettes and pipette tips into biohazard bin or used pipette tip container.

-

Count cells within 3-5 minutes of mixing suspension with trypan blue. Longer
incubation periods will result in reduced viability counts.
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E.3

Set-Up

E.3.1

Spray down work surface of laminar flow hood with IPA or ethanol and
wipe with Kimwipe.

E.3.2

Spray outer surfaces of all containers, then place in laminar flow hood.

E.4

Procedure

E.4.1

Using a sterile pipette tip, transfer 10 mL of cell suspension to centrifuge
tube. Discard pipette tip.

E.4.2

Centrifuge suspension at 5X speed for 5 minutes. Discard supernatant.

E.4.3

Using a sterile pipette tip, transfer 50 !L of serum-free culture medium to
centrifuge tube and gently mix with pipette to resuspend pellet.

E.4.4

Using a sterile pipette tip, transfer cell suspension to small centrifuge tube.

E.4.5

When ready to count cells, use a sterile pipette tip and transfer 50 !L of
trypan blue to small centrifuge tube containing suspension. Pipette up and
down gently to mix.

E.4.6

At both sides of hemocytometer inlets, use a 10 !L pipette ot add trypan
blue mixture until area with grid is fully exposed to mixture. DO NOT
OVERFILL!

E.4.7

Place hemocytometer on stage of inverted microscope and adjust power to
100X magnification.

E.4.8

Use handheld counters to count blue cells while also counting non-blue
cells. NOTE: Count cells that touch middle line of three-line border at top
and left sides only; discard cells that touch middle line at bottom and right
sides.
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E.5

Calculations

-

cells/mL = (# cells counted / # squares counted) * 104 * (1/5)

-

total cells = cells/mL * 0.2 mL

-

% viability = (# non-blue cells / total # of cells counted) * 100
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APPENDIX F - CELL PRINTER TEST PROTOCOL
F.1

Materials & Equipment

-

Cell suspension

-

10 mL Dubeco’s Modified Eagle’s Medium

-

2.5% glutaraldehyde solution from Appendix A

-

3 autoclaved, unassembled syringe assembly pouches

-

Culture plate or petri dish

-

Disposable 50 mL centrifuge tube

-

PXI chassis (National Instruments)

-

Dual DC-regulated power supply (Extech)

-

Cell printer system

F.2

Safety and Notes

-

Perform loading procedures in laminar flow hood.

-

Do not allow Trypan Blue or cell solution come in contact with skin.

-

Wear eye protection gloves, closed-toe shoes and pants when using hazardous
chemicals.

-

Discard pipettes and pipette tips into biohazard bin or used pipette tip container.

-

Minimize how long cell suspension is away from incubator.
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F.3

Set-Up

F.3.1

Prepare 2.5% solution of glutaraldehyde using Appendix A protocol.

F.3.2

Open cabinet door of cell printer and wipe down cabinet surface with
ethanol or IPA.

F.3.3

Wipe down inkjet nozzles with IPA or ethanol. Close cabinet door.

F.3.4

Shut down computer.

F.3.5

Power on PXI chassis, ensuring only power light is on.

F.3.6

Power up computer. Load LabView 7.1.

F.4

Procedure

F.4.1

Open cabinet door, and place beaker beneath inkjet nozzles. Lower
printer arm as much as possible to reduce splatter.

F.4.2

Assemble and fill one syringe reservoir with 2.5% glutaraldehyde,
following Appendix B protocol.

F.4.3

Assemble and fill one syringe reservoir with 5-10 mL of medium,
following Appendix B protocol.

F.4.4

Load system with glutaraldehyde-filled reservoir, following Appendix C
protocol.

F.4.5

Place disposable container beneath inkjet nozzles, and close cabinet door.

F.4.6

In LabView, open ‘Cleaning.vi’

F.4.7

Click on Run button to begin cleaning process.

F.4.8

Once 10-hour cycle completes, click on Purge button to purge any
remaining glutaraldehyde. IMPORTANT: Click on the Stop Purge button
once inkjet dispenses only air at least 6 consecutive times.

F.4.9

Unload used reservoir from system, following Appendix D protocol.

F.4.10

Load system with medium-filled reservoir, following Appendix C
protocol.
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F.4.11

In LabView, click on Start Media Purge button to flush system with
medium. IMPORTANT: Click on the Stop Media Purge button once
inkjet dispenses only air at least 6 consecutive times.

F.4.12

Unload used reservoir from system, following Appendix D protocol.

F.4.13

Remove disposable container from cabinet and discard.

F.4.14

Place culture plate/petri dish below inkjet nozzles. Lower inkjet head if
necessary, and close cabinet door.

F.4.15

Assemble and fill one syringe reservoir with the cell suspension, following
Appendix B protocol.

F.4.16

Load cell suspension reservoir into system, following Appendix C
protocol.

F.4.17

In LabView, open ‘Cell Printer Test.vi’

F.4.18

Configure number of deposits, “on” duration, and “off” duration to desired
settings.

F.4.19

Click on the Run button to begin printing cells.

F.4.20

Once print is complete, cover culture plate/petri dish and remove from
cabinet.

F.4.21

Place disposable container below inkjet nozzles and close cabinet.

F.4.22

In LabView, click on Purge button to purge any excess cell suspension
from printer. IMPORTANT: Click on Stop Purge button once inkjet
dispenses only air at least 6 consecutive times.

F.4.23

Seal, remove, and discard disposable container.

F.4.24

Perform Trypan Blue assay with suspension in culture plate/petri dish,
following Appendix E protocol.

99

APPENDIX G – PARTS LIST
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